DDI-MedLine.d31.s0|0-5|Cance|brand
DDI-MedLine.d31.s2|0-13|Rearrangement|brand
DDI-MedLine.d31.s3|0-4|Thes|brand
DDI-MedLine.d31.s3|6-12|factor|group
DDI-MedLine.d31.s3|31-43|age-dependen|drug_n
DDI-MedLine.d31.s5|0-3|Thi|brand
DDI-MedLine.d31.s5|31-42|development|group
DDI-MedLine.d129.s0|0-4|Gree|brand
DDI-MedLine.d129.s0|32-40|enhancer|group
DDI-MedLine.d129.s0|45-66|glucocorticoid-induce|drug_n
DDI-MedLine.d129.s1|44-49|ester|group
DDI-MedLine.d129.s1|54-75|glucocorticoid-induce|drug_n
DDI-MedLine.d129.s1|131-133|3Y|drug_n
DDI-MedLine.d129.s2|4-25|glucocorticoid-induce|drug_n
DDI-MedLine.d129.s2|89-94|ester|group
DDI-MedLine.d129.s3|0-8|n-dodecy|drug_n
DDI-MedLine.d129.s4|0-6|n-Octy|drug_n
DDI-MedLine.d129.s4|12-18|n-cety|drug_n
DDI-MedLine.d129.s5|60-60||drug_n
DDI-MedLine.d129.s5|62-90|-epigallocatechin-3-O-gallat|drug_n
DDI-MedLine.d129.s5|109-109||drug_n
DDI-MedLine.d129.s6|35-56|glucocorticoid-induce|drug_n
DDI-MedLine.d80.s0|0-13|Progestin-onl|brand
DDI-MedLine.d80.s1|79-92|progestin-onl|drug_n
DDI-MedLine.d80.s1|115-117|PO|drug_n
DDI-MedLine.d80.s1|127-128|U|drug_n
DDI-MedLine.d80.s2|91-94|POP|brand
DDI-MedLine.d80.s3|0-10|Conclusion|brand
DDI-MedLine.d80.s4|71-74|POC|brand
DDI-MedLine.d80.s5|0-5|Futur|brand
DDI-MedLine.d80.s6|0-6|Chapte|brand
DDI-MedLine.d80.s6|10-18|consider|group
DDI-MedLine.d80.s10|0-6|Chapte|brand
DDI-MedLine.d80.s10|10-15|cover|group
DDI-MedLine.d80.s10|31-46|pharmacokinetic|group
DDI-MedLine.d80.s10|49-64|pharmacodynamic|group
DDI-MedLine.d80.s11|17-24|present|group
DDI-MedLine.d80.s11|197-200|POC|brand
DDI-MedLine.d80.s12|0-6|Chapte|brand
DDI-MedLine.d80.s12|121-127|factor|group
DDI-MedLine.d80.s13|0-13|Cardiovascula|brand
DDI-MedLine.d80.s13|72-79|present|group
DDI-MedLine.d80.s13|143-149|cancer|group
DDI-MedLine.d80.s14|0-0||drug_n
DDI-MedLine.d80.s28|11-18|chapter|group
DDI-MedLine.d80.s28|65-69|test|group
DDI-MedLine.d80.s28|130-133|POC|brand
DDI-MedLine.d80.s29|0-10|Informatio|brand
DDI-MedLine.d41.s0|0-9|Interfero|brand
DDI-MedLine.d41.s1|0-7|Hithert|brand
DDI-MedLine.d41.s1|241-250|inhibitor|group
DDI-MedLine.d86.s0|0-14|Pharmacokineti|brand
DDI-MedLine.d86.s0|92-101|volunteer|group
DDI-MedLine.d86.s1|0-2|AI|drug_n
DDI-MedLine.d86.s1|4-6|AN|drug_n
DDI-MedLine.d86.s1|8-17|BACKGROUN|brand
DDI-MedLine.d86.s1|116-121|CYP3A|brand
DDI-MedLine.d86.s2|0-6|Severa|brand
DDI-MedLine.d86.s2|162-172|antagonist|group
DDI-MedLine.d86.s3|0-6|METHOD|brand
DDI-MedLine.d86.s3|9-15|Health|brand
DDI-MedLine.d86.s3|79-90|three-perio|drug_n
DDI-MedLine.d86.s3|128-143|pharmacokinetic|group
DDI-MedLine.d86.s3|157-161|10-m|drug_n
DDI-MedLine.d86.s3|201-206|120-m|drug_n
DDI-MedLine.d86.s4|44-49|21-da|drug_n
DDI-MedLine.d86.s5|0-6|RESULT|brand
DDI-MedLine.d86.s5|112-121|time-curv|drug_n
DDI-MedLine.d86.s5|141-143|-9|drug_n
DDI-MedLine.d86.s5|220-222|-8|drug_n
DDI-MedLine.d86.s5|310-318|half-lif|drug_n
DDI-MedLine.d86.s6|0-7|Apparen|brand
DDI-MedLine.d86.s7|59-76|concentration-tim|drug_n
DDI-MedLine.d86.s7|312-321|parameter|group
DDI-MedLine.d86.s8|0-10|CONCLUSION|brand
DDI-MedLine.d86.s8|13-23|Single-dos|brand
DDI-MedLine.d86.s8|120-129|first-pas|drug_n
DDI-MedLine.d86.s9|0-6|Becaus|brand
DDI-MedLine.d86.s9|72-90|sirolimus-diltiaze|drug_n
DDI-MedLine.d86.s9|173-180|patient|group
DDI-MedLine.d59.s0|0-0||drug_n
DDI-MedLine.d59.s0|45-57|cAMP-mediate|drug_n
DDI-MedLine.d59.s1|0-3|Aci|brand
DDI-MedLine.d59.s1|91-91||drug_n
DDI-MedLine.d59.s2|0-10|Stimulatio|brand
DDI-MedLine.d59.s3|121-130|inhibitor|group
DDI-MedLine.d59.s3|157-157||drug_n
DDI-MedLine.d59.s3|180-181|I|drug_n
DDI-MedLine.d59.s4|0-11|Cytochalasi|brand
DDI-MedLine.d59.s4|13-13||drug_n
DDI-MedLine.d59.s4|142-151|histamine|drug_n
DDI-MedLine.d59.s4|156-170|cAMP-stimulate|drug_n
DDI-MedLine.d59.s5|0-11|Cytochalasi|brand
DDI-MedLine.d59.s5|13-13||drug_n
DDI-MedLine.d59.s5|29-48|carbachol-stimulate|drug_n
DDI-MedLine.d59.s6|0-8|Treatmen|brand
DDI-MedLine.d59.s6|42-42||drug_n
DDI-MedLine.d59.s6|74-92|1,4,5-trisphosphat|drug_n
DDI-MedLine.d59.s7|0-4|Thes|brand
DDI-MedLine.d59.s7|254-267|microfilament|group
DDI-MedLine.d13.s0|0-4|Deat|brand
DDI-MedLine.d13.s0|9-19|amphetamin|drug
DDI-MedLine.d13.s0|21-25|user|group
DDI-MedLine.d13.s1|93-99|35-yea|drug_n
DDI-MedLine.d13.s2|0-4|Thes|brand
DDI-MedLine.d13.s2|37-45|accident|group
DDI-MedLine.d13.s4|16-22|Ontari|brand
DDI-MedLine.d13.s4|72-82|amphetamin|drug
DDI-MedLine.d13.s4|84-88|user|group
DDI-MedLine.d13.s6|0-8|Pulmonar|brand
DDI-MedLine.d13.s7|48-52|user|group
DDI-MedLine.d13.s7|69-79|amphetamin|drug
DDI-MedLine.d13.s7|84-90|Ontari|brand
DDI-MedLine.d13.s7|120-124|user|group
DDI-MedLine.d13.s7|232-241|alcoholic|group
DDI-MedLine.d13.s8|0-6|Howeve|brand
DDI-MedLine.d13.s8|32-46|alcohol-relate|drug_n
DDI-MedLine.d13.s8|99-109|amphetamin|drug
DDI-MedLine.d13.s8|121-125|user|group
DDI-MedLine.d79.s0|23-31|indinavi|drug
DDI-MedLine.d79.s0|34-36|ID|drug_n
DDI-MedLine.d79.s0|67-69|ID|drug_n
DDI-MedLine.d79.s1|0-9|Concurren|brand
DDI-MedLine.d79.s1|29-37|indinavi|drug
DDI-MedLine.d79.s1|101-109|indinavi|drug
DDI-MedLine.d79.s1|171-179|indinavi|drug
DDI-MedLine.d79.s2|12-20|indinavi|drug
DDI-MedLine.d79.s2|22-37|pharmacokinetic|group
DDI-MedLine.d79.s2|83-96|virus-positiv|drug_n
DDI-MedLine.d79.s2|98-105|patient|group
DDI-MedLine.d79.s2|127-135|indinavi|drug
DDI-MedLine.d79.s2|160-168|indinavi|drug
DDI-MedLine.d79.s3|0-5|Media|brand
DDI-MedLine.d79.s3|48-56|indinavi|drug
DDI-MedLine.d79.s4|96-113|concentration-tim|drug_n
DDI-MedLine.d79.s5|0-8|Indinavi|drug
DDI-MedLine.d19.s0|0-10|Anaesthesi|brand
DDI-MedLine.d19.s1|0-0||drug_n
DDI-MedLine.d19.s2|0-0||drug_n
DDI-MedLine.d19.s2|107-114|patient|group
DDI-MedLine.d19.s3|0-4|Ther|brand
DDI-MedLine.d19.s4|0-7|Numerou|brand
DDI-MedLine.d19.s4|65-70|agent|group
DDI-MedLine.d19.s4|100-108|phenytoi|drug
DDI-MedLine.d19.s5|0-4|Ther|brand
DDI-MedLine.d19.s5|58-65|patient|group
DDI-MedLine.d19.s5|108-113|agent|group
DDI-MedLine.d19.s5|145-147|CN|drug_n
DDI-MedLine.d50.s0|0-7|Ascorbi|brand
DDI-MedLine.d50.s1|0-9|Evaluatio|brand
DDI-MedLine.d50.s3|0-7|Althoug|brand
DDI-MedLine.d50.s4|0-8|Similarl|brand
DDI-MedLine.d45.s0|0-8|Selectiv|brand
DDI-MedLine.d45.s0|38-51|tripelennamin|drug
DDI-MedLine.d45.s0|56-66|Pseudomona|brand
DDI-MedLine.d45.s0|88-90|O1|drug_n
DDI-MedLine.d45.s1|14-24|Pseudomona|brand
DDI-MedLine.d45.s1|60-62|O1|drug_n
DDI-MedLine.d45.s1|84-97|tripelennamin|drug
DDI-MedLine.d45.s2|63-73|deep-seate|drug_n
DDI-MedLine.d45.s3|53-62|1,000-fol|drug_n
DDI-MedLine.d45.s3|79-89|Pseudomona|brand
DDI-MedLine.d45.s3|198-198||drug_n
DDI-MedLine.d45.s4|0-0||drug_n
DDI-MedLine.d45.s4|43-45|O1|drug_n
DDI-MedLine.d45.s5|0-5|Twelv|brand
DDI-MedLine.d45.s5|18-31|Staphylococcu|brand
DDI-MedLine.d45.s5|109-122|tripelennamin|drug
DDI-MedLine.d45.s6|0-12|Dose-respons|brand
DDI-MedLine.d45.s6|84-90|powder|group
DDI-MedLine.d45.s6|105-118|tripelennamin|drug
DDI-MedLine.d45.s7|36-36||drug_n
DDI-MedLine.d45.s8|20-22|O1|drug_n
DDI-MedLine.d45.s8|41-41||drug_n
DDI-MedLine.d45.s9|38-51|tripelennamin|drug
DDI-MedLine.d45.s9|86-86||drug_n
DDI-MedLine.d45.s10|10-10||drug_n
DDI-MedLine.d56.s0|0-3|Dua|brand
DDI-MedLine.d56.s0|30-46|palytoxin-induce|drug_n
DDI-MedLine.d56.s0|94-103|guinea-pi|drug_n
DDI-MedLine.d56.s1|0-8|Palytoxi|brand
DDI-MedLine.d56.s1|11-13|PT|drug_n
DDI-MedLine.d56.s1|17-29|C129H223N3O5|brand
DDI-MedLine.d56.s1|70-77|Palytho|brand
DDI-MedLine.d56.s1|168-177|guinea-pi|drug_n
DDI-MedLine.d56.s2|31-32|-|drug_n
DDI-MedLine.d56.s2|35-35||drug_n
DDI-MedLine.d56.s2|39-41|PT|drug_n
DDI-MedLine.d56.s2|47-48|-|drug_n
DDI-MedLine.d56.s2|51-51||drug_n
DDI-MedLine.d56.s4|19-30|phentolamin|drug
DDI-MedLine.d56.s4|36-37|-|drug_n
DDI-MedLine.d56.s4|40-40||drug_n
DDI-MedLine.d56.s5|0-3|Whe|brand
DDI-MedLine.d56.s5|58-69|phentolamin|drug
DDI-MedLine.d56.s5|119-121|PT|drug_n
DDI-MedLine.d56.s6|0-3|Whe|brand
DDI-MedLine.d56.s6|35-52|potassium-deplete|drug_n
DDI-MedLine.d56.s6|98-100|PT|drug_n
DDI-MedLine.d56.s7|0-2|PT|drug_n
DDI-MedLine.d56.s8|0-7|Exposur|brand
DDI-MedLine.d56.s8|38-39|-|drug_n
DDI-MedLine.d56.s8|42-42||drug_n
DDI-MedLine.d56.s8|68-78|PTX-induce|brand
DDI-MedLine.d56.s9|67-69|PT|drug_n
DDI-MedLine.d56.s11|31-33|PT|drug_n
DDI-MedLine.d56.s11|73-80|K-ATPas|brand
DDI-MedLine.d16.s0|0-10|Interactio|brand
DDI-MedLine.d16.s0|15-22|ketamin|drug
DDI-MedLine.d16.s1|44-51|ketamin|drug
DDI-MedLine.d16.s1|61-74|N-demethylate|brand
DDI-MedLine.d16.s1|99-99||drug_n
DDI-MedLine.d16.s2|0-3|Fiv|brand
DDI-MedLine.d16.s2|29-36|ketamin|drug
DDI-MedLine.d16.s2|82-82||drug_n
DDI-MedLine.d16.s3|0-6|Howeve|brand
DDI-MedLine.d16.s3|49-51|MA|drug_n
DDI-MedLine.d16.s3|73-86|dose-dependen|drug_n
DDI-MedLine.d16.s3|111-113|1-|drug_n
DDI-MedLine.d16.s3|140-142|5-|drug_n
DDI-MedLine.d16.s3|169-176|ketamin|drug
DDI-MedLine.d16.s4|17-19|MA|drug_n
DDI-MedLine.d16.s4|57-64|ketamin|drug
DDI-MedLine.d16.s4|80-80||drug_n
DDI-MedLine.d16.s4|96-103|ketamin|drug
DDI-MedLine.d16.s4|116-116||drug_n
DDI-MedLine.d16.s5|4-12|half-lif|drug_n
DDI-MedLine.d16.s5|17-24|ketamin|drug
DDI-MedLine.d16.s5|96-103|ketamin|drug
DDI-MedLine.d16.s6|21-28|ketamin|drug
DDI-MedLine.d16.s6|39-50|short-actin|drug_n
DDI-MedLine.d104.s0|15-20|DCG-I|brand
DDI-MedLine.d104.s0|26-32|L-CCG-|brand
DDI-MedLine.d104.s0|39-51|phencyclidin|drug
DDI-MedLine.d104.s0|54-56|PC|drug_n
DDI-MedLine.d104.s0|58-65|-induce|drug_n
DDI-MedLine.d104.s2|13-25|phencyclidin|drug
DDI-MedLine.d104.s2|28-30|PC|drug_n
DDI-MedLine.d104.s3|0-3|The|brand
DDI-MedLine.d104.s3|61-68|agonist|group
DDI-MedLine.d104.s3|71-76|DCG-I|brand
DDI-MedLine.d104.s3|82-88|L-CCG-|brand
DDI-MedLine.d104.s3|134-136|PC|drug_n
DDI-MedLine.d104.s4|15-20|DCG-I|brand
DDI-MedLine.d104.s4|68-78|PCP-induce|brand
DDI-MedLine.d104.s5|15-21|L-CCG-|brand
DDI-MedLine.d104.s6|0-7|Repeate|brand
DDI-MedLine.d104.s6|22-24|PC|drug_n
DDI-MedLine.d104.s7|0-4|Thes|brand
DDI-MedLine.d104.s8|12-18|examin|drug
DDI-MedLine.d104.s8|49-59|PCP-induce|brand
DDI-MedLine.d104.s8|81-88|Norther|brand
DDI-MedLine.d104.s8|113-115|RN|drug_n
DDI-MedLine.d104.s8|171-173|PC|drug_n
DDI-MedLine.d104.s8|176-181|DCG-I|brand
DDI-MedLine.d104.s8|188-194|L-CCG-|brand
DDI-MedLine.d42.s0|0-9|Sildenafi|brand
DDI-MedLine.d42.s1|0-9|BACKGROUN|brand
DDI-MedLine.d42.s1|12-16|Sinc|brand
DDI-MedLine.d42.s1|38-39|U|drug_n
DDI-MedLine.d42.s1|41-44|Foo|brand
DDI-MedLine.d42.s1|50-53|Dru|brand
DDI-MedLine.d42.s1|55-68|Administratio|brand
DDI-MedLine.d42.s1|73-77|Marc|brand
DDI-MedLine.d42.s2|0-5|Recen|brand
DDI-MedLine.d42.s3|0-8|OBJECTIV|brand
DDI-MedLine.d42.s3|11-14|Thi|brand
DDI-MedLine.d42.s3|137-143|factor|group
DDI-MedLine.d42.s3|305-313|disorder|group
DDI-MedLine.d42.s4|0-6|METHOD|brand
DDI-MedLine.d42.s4|9-16|Clinica|brand
DDI-MedLine.d42.s4|145-151|Januar|brand
DDI-MedLine.d42.s4|162-167|Augus|brand
DDI-MedLine.d42.s4|210-216|MEDLIN|brand
DDI-MedLine.d42.s4|219-228|PREMEDLIN|brand
DDI-MedLine.d42.s4|235-247|Internationa|brand
DDI-MedLine.d42.s4|249-262|Pharmaceutica|brand
DDI-MedLine.d42.s4|264-272|Abstract|brand
DDI-MedLine.d42.s4|303-308|Viagr|brand
DDI-MedLine.d42.s5|0-6|RESULT|brand
DDI-MedLine.d42.s5|9-18|Sildenafi|brand
DDI-MedLine.d42.s5|172-180|disorder|group
DDI-MedLine.d42.s5|234-243|inhibitor|group
DDI-MedLine.d42.s5|246-250|SSRI|brand
DDI-MedLine.d42.s6|85-99|SSRI-associate|brand
DDI-MedLine.d42.s7|0-3|Som|brand
DDI-MedLine.d42.s7|5-13|disorder|group
DDI-MedLine.d42.s9|9-16|patient|group
DDI-MedLine.d42.s10|13-20|patient|group
DDI-MedLine.d42.s10|63-66|P45|brand
DDI-MedLine.d42.s10|68-70|3A|drug_n
DDI-MedLine.d42.s11|0-10|CONCLUSION|brand
DDI-MedLine.d42.s11|13-22|Sildenafi|brand
DDI-MedLine.d42.s11|40-49|first-lin|drug_n
DDI-MedLine.d42.s12|79-95|cost-risk-benefi|drug_n
DDI-MedLine.d25.s0|0-13|Rhabdomyolysi|brand
DDI-MedLine.d25.s0|55-65|simvastati|drug
DDI-MedLine.d25.s0|71-84|clarithromyci|drug
DDI-MedLine.d25.s1|0-8|OBJECTIV|brand
DDI-MedLine.d25.s1|80-93|clarithromyci|drug
DDI-MedLine.d25.s1|99-109|simvastati|drug
DDI-MedLine.d25.s2|0-3|CAS|brand
DDI-MedLine.d25.s2|5-11|SUMMAR|brand
DDI-MedLine.d25.s2|14-14||drug_n
DDI-MedLine.d25.s2|16-26|64-year-ol|drug_n
DDI-MedLine.d25.s2|28-43|African-America|brand
DDI-MedLine.d25.s3|0-4|Abou|brand
DDI-MedLine.d25.s3|65-78|clarithromyci|drug
DDI-MedLine.d25.s4|31-41|simvastati|drug
DDI-MedLine.d25.s6|0-0||drug_n
DDI-MedLine.d25.s8|0-4|Ther|brand
DDI-MedLine.d25.s8|19-25|factor|group
DDI-MedLine.d25.s9|0-9|DISCUSSIO|brand
DDI-MedLine.d25.s9|12-25|Clarithromyci|drug
DDI-MedLine.d25.s9|52-57|CYP3A|brand
DDI-MedLine.d25.s9|93-103|simvastati|drug
DDI-MedLine.d25.s10|44-54|antibiotic|group
DDI-MedLine.d25.s10|97-97||drug_n
DDI-MedLine.d25.s10|100-106|HMG-Co|brand
DDI-MedLine.d25.s10|119-128|inhibitor|group
DDI-MedLine.d25.s11|0-4|Othe|brand
DDI-MedLine.d25.s11|6-12|factor|group
DDI-MedLine.d25.s11|215-221|HMG-Co|brand
DDI-MedLine.d25.s11|233-242|inhibitor|group
DDI-MedLine.d25.s12|0-10|CONCLUSION|brand
DDI-MedLine.d25.s12|13-21|Macrolid|brand
DDI-MedLine.d25.s12|23-33|antibiotic|group
DDI-MedLine.d25.s12|61-67|HMG-Co|brand
DDI-MedLine.d25.s12|79-88|inhibitor|group
DDI-MedLine.d25.s12|114-119|CYP3A|brand
DDI-MedLine.d25.s12|128-139|atorvastati|drug
DDI-MedLine.d25.s12|142-153|cerivastati|drug
DDI-MedLine.d25.s12|156-165|lovastati|drug
DDI-MedLine.d25.s12|168-178|simvastati|drug
DDI-MedLine.d25.s13|0-3|Thi|brand
DDI-MedLine.d25.s13|76-83|patient|group
DDI-MedLine.d70.s0|0-7|Toxicit|brand
DDI-MedLine.d70.s0|45-55|Schistosom|brand
DDI-MedLine.d70.s1|120-130|Schistosom|brand
DDI-MedLine.d70.s3|0-4|Meta|brand
DDI-MedLine.d70.s4|71-80|1000-1000|drug_n
DDI-MedLine.d70.s5|0-4|Meta|brand
DDI-MedLine.d70.s6|0-7|Surviva|brand
DDI-MedLine.d70.s7|0-8|Miracidi|brand
DDI-MedLine.d126.s0|0-19|Cypermethrin-induce|brand
DDI-MedLine.d126.s0|85-85||drug_n
DDI-MedLine.d126.s1|0-10|Considerin|brand
DDI-MedLine.d126.s1|61-63|RO|drug_n
DDI-MedLine.d126.s1|229-232|Typ|brand
DDI-MedLine.d126.s1|234-235|I|drug_n
DDI-MedLine.d126.s2|0-5|Eithe|brand
DDI-MedLine.d126.s2|284-288|TBAR|brand
DDI-MedLine.d126.s3|0-3|Muc|brand
DDI-MedLine.d126.s4|0-6|Reduce|brand
DDI-MedLine.d126.s4|55-57|GS|drug_n
DDI-MedLine.d126.s5|0-24|Glutathione-S-transferas|brand
DDI-MedLine.d126.s5|27-29|GS|drug_n
DDI-MedLine.d126.s6|0-11|Pretreatmen|brand
DDI-MedLine.d126.s6|57-63|Vitami|brand
DDI-MedLine.d126.s6|65-65||drug_n
DDI-MedLine.d126.s6|198-202|TBAR|brand
DDI-MedLine.d126.s7|0-3|Thu|brand
DDI-MedLine.d126.s7|77-92|radical-mediate|drug_n
DDI-MedLine.d126.s7|214-220|Vitami|brand
DDI-MedLine.d126.s7|222-222||drug_n
DDI-MedLine.d68.s0|15-24|cimetidin|drug
DDI-MedLine.d68.s0|67-74|iodamid|drug
DDI-MedLine.d68.s0|115-124|cimetidin|drug
DDI-MedLine.d68.s0|173-180|iodamid|drug
DDI-MedLine.d68.s0|210-220|experiment|group
DDI-MedLine.d68.s1|27-34|iodamid|drug
DDI-MedLine.d68.s2|9-18|cimetidin|drug
DDI-MedLine.d68.s3|0-7|Possibl|brand
DDI-MedLine.d68.s3|44-53|cimetidin|drug
DDI-MedLine.d68.s3|74-81|iodamid|drug
DDI-MedLine.d119.s0|0-10|Developmen|brand
DDI-MedLine.d119.s0|32-42|fluvastati|drug
DDI-MedLine.d119.s1|0-10|Fluvastati|drug
DDI-MedLine.d119.s1|35-60|3-hydroxy-3-methylglutary|drug_n
DDI-MedLine.d119.s1|71-71||drug_n
DDI-MedLine.d119.s1|74-79|HMGCo|brand
DDI-MedLine.d119.s2|63-68|HMGCo|brand
DDI-MedLine.d119.s2|80-89|inhibitor|group
DDI-MedLine.d119.s2|92-101|lovastati|drug
DDI-MedLine.d119.s2|104-114|simvastati|drug
DDI-MedLine.d119.s2|121-131|pravastati|drug
DDI-MedLine.d119.s2|204-209|agent|group
DDI-MedLine.d119.s3|0-9|Absorptio|brand
DDI-MedLine.d119.s3|14-24|fluvastati|drug
DDI-MedLine.d119.s4|0-7|Systemi|brand
DDI-MedLine.d119.s4|33-43|fluvastati|drug
DDI-MedLine.d119.s4|59-68|first-pas|drug_n
DDI-MedLine.d119.s4|97-105|half-lif|drug_n
DDI-MedLine.d119.s5|0-3|Som|brand
DDI-MedLine.d119.s5|31-41|fluvastati|drug
DDI-MedLine.d119.s6|0-11|Additionall|brand
DDI-MedLine.d119.s7|0-6|Studie|brand
DDI-MedLine.d119.s7|37-52|pharmacokinetic|group
DDI-MedLine.d119.s7|57-67|fluvastati|drug
DDI-MedLine.d119.s7|135-136|-|drug_n
DDI-MedLine.d119.s8|25-35|fluvastati|drug
DDI-MedLine.d119.s9|0-10|Furthermor|brand
DDI-MedLine.d119.s9|79-89|low-densit|drug_n
DDI-MedLine.d119.s10|4-19|pharmacokinetic|group
DDI-MedLine.d119.s10|24-34|fluvastati|drug
DDI-MedLine.d119.s11|0-7|Relativ|brand
DDI-MedLine.d119.s11|61-71|fluvastati|drug
DDI-MedLine.d119.s12|93-100|2.5-fol|drug_n
DDI-MedLine.d119.s13|0-3|Als|brand
DDI-MedLine.d119.s13|38-48|fluvastati|drug
DDI-MedLine.d119.s13|63-70|patient|group
DDI-MedLine.d119.s13|205-211|examin|drug
DDI-MedLine.d119.s14|0-10|Interactio|brand
DDI-MedLine.d119.s14|45-55|fluvastati|drug
DDI-MedLine.d119.s15|0-13|Cholestyramin|drug
DDI-MedLine.d119.s15|19-33|anionic-bindin|drug_n
DDI-MedLine.d119.s15|103-113|fluvastati|drug
DDI-MedLine.d119.s16|0-7|Althoug|brand
DDI-MedLine.d119.s16|41-54|cholestyramin|drug
DDI-MedLine.d119.s16|83-93|fluvastati|drug
DDI-MedLine.d119.s17|0-6|Furthe|brand
DDI-MedLine.d119.s17|30-37|warfari|drug
DDI-MedLine.d119.s17|132-139|warfari|drug
DDI-MedLine.d119.s17|145-155|fluvastati|drug
DDI-MedLine.d119.s18|0-7|Moreove|brand
DDI-MedLine.d119.s18|105-115|fluvastati|drug
DDI-MedLine.d119.s18|197-203|digoxi|drug
DDI-MedLine.d119.s18|267-273|digoxi|drug
DDI-MedLine.d119.s19|71-81|fluvastati|drug
DDI-MedLine.d119.s19|151-158|patient|group
DDI-MedLine.d94.s0|0-7|Evidenc|brand
DDI-MedLine.d94.s1|0-9|OBJECTIVE|brand
DDI-MedLine.d94.s2|0-3|Thi|brand
DDI-MedLine.d94.s2|71-78|uptake-|drug_n
DDI-MedLine.d94.s3|0-9|BACKGROUN|brand
DDI-MedLine.d94.s4|0-6|Severa|brand
DDI-MedLine.d94.s4|8-22|beta-adrenergi|drug_n
DDI-MedLine.d94.s5|0-6|Whethe|brand
DDI-MedLine.d94.s5|40-47|uptake-|drug_n
DDI-MedLine.d94.s6|0-6|METHOD|brand
DDI-MedLine.d94.s7|27-34|uptake-|drug_n
DDI-MedLine.d94.s7|93-93||drug_n
DDI-MedLine.d94.s8|0-6|RESULT|brand
DDI-MedLine.d94.s10|80-83|Yor|brand
DDI-MedLine.d94.s10|85-89|Hear|brand
DDI-MedLine.d94.s10|91-101|Associatio|brand
DDI-MedLine.d94.s10|120-121|I|drug_n
DDI-MedLine.d94.s10|195-198|EC5|brand
DDI-MedLine.d94.s11|4-7|EC5|brand
DDI-MedLine.d94.s11|79-86|uptake-|drug_n
DDI-MedLine.d94.s11|138-139|I|drug_n
DDI-MedLine.d94.s11|144-146|II|drug_n
DDI-MedLine.d94.s11|152-153|I|drug_n
DDI-MedLine.d94.s12|11-20|inhibitor|group
DDI-MedLine.d94.s12|34-44|desipramin|drug
DDI-MedLine.d94.s12|187-188|I|drug_n
DDI-MedLine.d94.s13|0-10|Radioligan|brand
DDI-MedLine.d94.s13|20-30|experiment|group
DDI-MedLine.d94.s13|59-68|hydrogen-|drug_n
DDI-MedLine.d94.s13|150-157|uptake-|drug_n
DDI-MedLine.d94.s13|197-198|I|drug_n
DDI-MedLine.d94.s13|203-205|II|drug_n
DDI-MedLine.d94.s13|211-212|I|drug_n
DDI-MedLine.d94.s14|0-10|CONCLUSION|brand
DDI-MedLine.d94.s15|108-115|uptake-|drug_n
DDI-MedLine.d94.s16|0-3|Thi|brand
DDI-MedLine.d94.s16|83-88|agent|group
DDI-MedLine.d94.s16|111-121|desipramin|drug
DDI-MedLine.d94.s17|0-10|Compromise|brand
DDI-MedLine.d94.s17|27-34|uptake-|drug_n
DDI-MedLine.d94.s17|56-57|I|drug_n
DDI-MedLine.d94.s17|102-112|desipramin|drug
DDI-MedLine.d110.s0|0-21|18-Methoxycoronaridin|drug
DDI-MedLine.d110.s0|24-28|18-M|drug_n
DDI-MedLine.d110.s1|0-4|18-M|drug_n
DDI-MedLine.d110.s2|0-3|Lik|brand
DDI-MedLine.d110.s2|26-30|18-M|drug_n
DDI-MedLine.d110.s2|69-87|self-administratio|drug_n
DDI-MedLine.d110.s2|126-144|self-administratio|drug_n
DDI-MedLine.d110.s3|17-21|18-M|drug_n
DDI-MedLine.d110.s4|0-3|Bot|brand
DDI-MedLine.d110.s4|18-22|18-M|drug_n
DDI-MedLine.d110.s5|0-3|Bot|brand
DDI-MedLine.d110.s5|18-22|18-M|drug_n
DDI-MedLine.d110.s5|57-64|dopamin|drug
DDI-MedLine.d110.s6|0-3|Bot|brand
DDI-MedLine.d110.s6|18-22|18-M|drug_n
DDI-MedLine.d110.s6|30-45|morphine-induce|drug_n
DDI-MedLine.d110.s6|51-66|nicotine-induce|drug_n
DDI-MedLine.d110.s6|68-75|dopamin|drug
DDI-MedLine.d110.s7|23-37|cocaine-induce|drug_n
DDI-MedLine.d110.s7|61-68|dopamin|drug
DDI-MedLine.d110.s8|0-3|Bot|brand
DDI-MedLine.d110.s8|18-22|18-M|drug_n
DDI-MedLine.d110.s8|76-85|stimulant|group
DDI-MedLine.d110.s9|0-7|Ibogain|brand
DDI-MedLine.d110.s9|25-29|18-M|drug_n
DDI-MedLine.d110.s10|25-40|morphine-induce|drug_n
DDI-MedLine.d110.s10|56-75|morphine-experience|drug_n
DDI-MedLine.d110.s11|0-7|Ibogain|brand
DDI-MedLine.d110.s11|29-35|tremor|group
DDI-MedLine.d110.s12|0-4|18-M|drug_n
DDI-MedLine.d110.s13|0-7|Ibogain|brand
DDI-MedLine.d110.s13|18-22|18-M|drug_n
DDI-MedLine.d110.s14|0-4|Whil|brand
DDI-MedLine.d110.s14|6-10|18-M|drug_n
DDI-MedLine.d110.s14|89-97|receptor|group
DDI-MedLine.d110.s14|100-104|18-M|drug_n
DDI-MedLine.d110.s14|150-153|NMD|brand
DDI-MedLine.d110.s14|159-165|sigma-|drug_n
DDI-MedLine.d110.s14|167-175|receptor|group
DDI-MedLine.d110.s14|203-206|5-H|drug_n
DDI-MedLine.d110.s15|0-3|Bot|brand
DDI-MedLine.d110.s15|5-9|18-M|drug_n
DDI-MedLine.d110.s15|67-71|18-M|drug_n
DDI-MedLine.d110.s16|22-26|18-M|drug_n
DDI-MedLine.d72.s0|1-13|Pharmacologi|brand
DDI-MedLine.d72.s0|39-48|treatment|group
DDI-MedLine.d72.s0|124-133|OBJECTIVE|brand
DDI-MedLine.d72.s0|204-207|PIC|brand
DDI-MedLine.d72.s0|249-251|MA|drug_n
DDI-MedLine.d72.s1|0-5|DESIG|brand
DDI-MedLine.d72.s1|8-22|Cross-sectiona|brand
DDI-MedLine.d72.s2|0-6|SETTIN|brand
DDI-MedLine.d72.s2|9-13|Rura|brand
DDI-MedLine.d72.s3|0-7|PATIENT|brand
DDI-MedLine.d72.s3|10-15|Rando|brand
DDI-MedLine.d72.s3|31-33|MA|drug_n
DDI-MedLine.d72.s4|0-11|MEASUREMENT|brand
DDI-MedLine.d72.s4|13-15|AN|drug_n
DDI-MedLine.d72.s4|17-20|MAI|brand
DDI-MedLine.d72.s4|22-28|RESULT|brand
DDI-MedLine.d72.s4|34-41|Decembe|brand
DDI-MedLine.d72.s4|86-88|MA|drug_n
DDI-MedLine.d72.s4|232-233|P|drug_n
DDI-MedLine.d72.s4|268-274|Hanste|brand
DDI-MedLine.d72.s5|0-10|Statistica|brand
DDI-MedLine.d72.s5|22-36|Mantel-Haensze|brand
DDI-MedLine.d72.s6|0-7|Patient|brand
DDI-MedLine.d72.s6|33-34|C|drug_n
DDI-MedLine.d72.s6|37-39|+/|drug_n
DDI-MedLine.d72.s7|0-3|Mea|brand
DDI-MedLine.d72.s7|25-27|MA|drug_n
DDI-MedLine.d72.s7|40-41|C|drug_n
DDI-MedLine.d72.s7|44-46|+/|drug_n
DDI-MedLine.d72.s8|4-5|P|drug_n
DDI-MedLine.d72.s8|21-28|patient|group
DDI-MedLine.d72.s8|42-43|C|drug_n
DDI-MedLine.d72.s8|46-48|+/|drug_n
DDI-MedLine.d72.s9|11-12|C|drug_n
DDI-MedLine.d72.s9|15-17|+/|drug_n
DDI-MedLine.d72.s9|29-32|PIC|brand
DDI-MedLine.d72.s9|58-59|C|drug_n
DDI-MedLine.d72.s9|62-64|+/|drug_n
DDI-MedLine.d72.s9|78-80|MA|drug_n
DDI-MedLine.d72.s10|17-18|P|drug_n
DDI-MedLine.d72.s11|0-4|Ther|brand
DDI-MedLine.d72.s11|14-15|P|drug_n
DDI-MedLine.d72.s11|62-63|C|drug_n
DDI-MedLine.d72.s11|66-68|+/|drug_n
DDI-MedLine.d72.s12|11-12|C|drug_n
DDI-MedLine.d72.s12|15-17|+/|drug_n
DDI-MedLine.d72.s12|37-40|PIC|brand
DDI-MedLine.d72.s13|29-30|C|drug_n
DDI-MedLine.d72.s13|33-35|+/|drug_n
DDI-MedLine.d72.s13|60-68|follow-u|drug_n
DDI-MedLine.d72.s13|73-80|patient|group
DDI-MedLine.d72.s14|0-10|CONCLUSION|brand
DDI-MedLine.d72.s14|87-90|PIC|brand
DDI-MedLine.d72.s15|0-3|Fou|brand
DDI-MedLine.d72.s15|52-55|PIC|brand
DDI-MedLine.d48.s0|0-11|Modificatio|brand
DDI-MedLine.d48.s0|24-32|histidin|drug
DDI-MedLine.d48.s0|79-89|Clostridiu|brand
DDI-MedLine.d48.s0|107-107||drug_n
DDI-MedLine.d48.s1|0-10|Clostridiu|brand
DDI-MedLine.d48.s1|28-28||drug_n
DDI-MedLine.d48.s2|45-45||drug_n
DDI-MedLine.d48.s2|109-119|GTP-bindin|brand
DDI-MedLine.d48.s3|0-6|Diethy|brand
DDI-MedLine.d48.s3|72-80|histidin|drug
DDI-MedLine.d48.s3|100-100||drug_n
DDI-MedLine.d48.s4|0-11|Modificatio|brand
DDI-MedLine.d48.s4|22-22||drug_n
DDI-MedLine.d48.s4|126-137|Zn-Sepharos|brand
DDI-MedLine.d48.s5|0-8|Treatmen|brand
DDI-MedLine.d48.s5|19-19||drug_n
DDI-MedLine.d48.s5|31-31||drug_n
DDI-MedLine.d48.s5|33-40|-diethy|drug_n
DDI-MedLine.d48.s5|102-110|histidin|drug
DDI-MedLine.d48.s6|58-70|hydroxylamin|drug
DDI-MedLine.d48.s7|0-4|Thes|brand
DDI-MedLine.d48.s7|32-40|histidin|drug
DDI-MedLine.d48.s7|60-60||drug_n
DDI-MedLine.d48.s8|0-8|Histidin|drug
DDI-MedLine.d48.s8|90-90||drug_n
DDI-MedLine.d48.s9|0-6|Howeve|brand
DDI-MedLine.d48.s9|90-94|ELIS|brand
DDI-MedLine.d48.s10|26-34|histidin|drug
DDI-MedLine.d48.s10|67-82|receptor-bindin|drug_n
DDI-MedLine.d48.s10|102-102||drug_n
DDI-MedLine.d48.s11|0-6|Expose|brand
DDI-MedLine.d48.s11|28-28||drug_n
DDI-MedLine.d48.s11|156-156||drug_n
DDI-MedLine.d48.s11|164-177|zinc-chelatin|drug_n
DDI-MedLine.d35.s0|1-10|Importanc|brand
DDI-MedLine.d35.s0|15-30|pharmacogenetic|group
DDI-MedLine.d35.s0|34-49|Pharmacogenetic|brand
DDI-MedLine.d35.s1|0-10|Difference|brand
DDI-MedLine.d35.s1|59-64|event|group
DDI-MedLine.d35.s2|0-6|Geneti|brand
DDI-MedLine.d35.s2|124-135|metabolizer|group
DDI-MedLine.d35.s2|180-194|antidepressant|group
DDI-MedLine.d35.s3|0-6|Geneti|brand
DDI-MedLine.d35.s4|17-30|antipsychotic|group
DDI-MedLine.d35.s6|0-6|Howeve|brand
DDI-MedLine.d35.s6|89-100|appointment|group
DDI-MedLine.d35.s6|114-121|patient|group
DDI-MedLine.d35.s7|0-8|Therefor|brand
DDI-MedLine.d33.s0|0-11|Determinant|brand
DDI-MedLine.d33.s0|40-62|topoisomerase-targetin|drug_n
DDI-MedLine.d33.s3|33-33||drug_n
DDI-MedLine.d33.s4|0-4|Smal|brand
DDI-MedLine.d33.s4|117-129|type-specifi|drug_n
DDI-MedLine.d33.s4|160-171|determinant|group
DDI-MedLine.d33.s5|0-6|Whethe|brand
DDI-MedLine.d33.s5|111-132|topoisomerase-targete|drug_n
DDI-MedLine.d33.s6|0-11|Determinant|brand
DDI-MedLine.d33.s6|144-155|DNA-damagin|brand
DDI-MedLine.d33.s6|157-162|agent|group
DDI-MedLine.d33.s8|0-3|Bot|brand
DDI-MedLine.d114.s0|0-9|Inhibitor|brand
DDI-MedLine.d114.s0|53-75|5-trisphosphate-induce|drug_n
DDI-MedLine.d114.s1|30-31|R|drug_n
DDI-MedLine.d114.s1|46-64|1,4,5-trisphosphat|drug_n
DDI-MedLine.d114.s1|67-70|Ins|brand
DDI-MedLine.d114.s1|75-82|-induce|drug_n
DDI-MedLine.d114.s1|150-160|patch-clam|drug_n
DDI-MedLine.d114.s1|162-171|whole-cel|drug_n
DDI-MedLine.d114.s1|213-218|fura-|drug_n
DDI-MedLine.d114.s2|0-7|Interna|brand
DDI-MedLine.d114.s2|24-27|Ins|brand
DDI-MedLine.d114.s2|128-137|-dependen|drug_n
DDI-MedLine.d114.s2|139-139||drug_n
DDI-MedLine.d114.s3|0-12|Administerin|brand
DDI-MedLine.d114.s3|14-17|Ins|brand
DDI-MedLine.d114.s3|36-37|R|drug_n
DDI-MedLine.d114.s3|40-46|100-50|drug_n
DDI-MedLine.d114.s3|66-69|Ins|brand
DDI-MedLine.d114.s3|73-80|-induce|drug_n
DDI-MedLine.d114.s3|133-146|dose-dependen|drug_n
DDI-MedLine.d114.s4|0-11|Pretreatmen|brand
DDI-MedLine.d114.s4|50-51|R|drug_n
DDI-MedLine.d114.s4|80-83|Ins|brand
DDI-MedLine.d114.s4|87-94|-induce|drug_n
DDI-MedLine.d114.s5|0-12|Intracellula|brand
DDI-MedLine.d114.s5|47-48|R|drug_n
DDI-MedLine.d114.s5|58-68|ADP-induce|brand
DDI-MedLine.d114.s6|57-58|R|drug_n
DDI-MedLine.d114.s6|77-80|Ins|brand
DDI-MedLine.d114.s6|84-91|-induce|drug_n
DDI-MedLine.d114.s7|0-4|Take|brand
DDI-MedLine.d114.s7|80-81|R|drug_n
DDI-MedLine.d114.s7|93-96|Ins|brand
DDI-MedLine.d114.s8|32-33|R|drug_n
DDI-MedLine.d114.s8|82-88|examin|drug
DDI-MedLine.d114.s8|94-97|Ins|brand
DDI-MedLine.d114.s8|101-109|-mediate|drug_n
DDI-MedLine.d23.s0|15-22|ketamin|drug
DDI-MedLine.d23.s0|31-37|Innova|brand
DDI-MedLine.d23.s0|53-61|digitali|group
DDI-MedLine.d23.s1|19-27|digitali|group
DDI-MedLine.d23.s1|65-72|ketamin|drug
DDI-MedLine.d23.s1|75-81|Innova|brand
DDI-MedLine.d23.s1|205-208|LD5|brand
DDI-MedLine.d23.s1|227-234|ketamin|drug
DDI-MedLine.d23.s1|239-245|Innova|brand
DDI-MedLine.d23.s2|0-10|Ventricula|brand
DDI-MedLine.d23.s2|111-117|Innova|brand
DDI-MedLine.d23.s2|120-127|ketamin|drug
DDI-MedLine.d90.s0|0-10|Interactio|brand
DDI-MedLine.d90.s0|15-24|gentamyci|drug
DDI-MedLine.d90.s1|0-5|Evoke|brand
DDI-MedLine.d90.s2|0-4|Afte|brand
DDI-MedLine.d90.s3|0-9|Atracuriu|brand
DDI-MedLine.d90.s4|0-9|Atracuriu|brand
DDI-MedLine.d90.s5|0-9|Gentamyci|drug
DDI-MedLine.d90.s5|43-45|+/|drug_n
DDI-MedLine.d90.s5|56-58|+/|drug_n
DDI-MedLine.d90.s5|71-73|+/|drug_n
DDI-MedLine.d90.s5|89-91|+/|drug_n
DDI-MedLine.d90.s5|102-102||drug_n
DDI-MedLine.d90.s6|0-5|Twitc|brand
DDI-MedLine.d90.s6|29-42|pre-gentamyci|drug
DDI-MedLine.d90.s7|0-7|Recover|brand
DDI-MedLine.d90.s7|49-51|+/|drug_n
DDI-MedLine.d90.s7|91-93|+/|drug_n
DDI-MedLine.d90.s7|123-132|gentamyci|drug
DDI-MedLine.d90.s7|135-135||drug_n
DDI-MedLine.d90.s8|0-7|Recover|brand
DDI-MedLine.d90.s8|56-58|+/|drug_n
DDI-MedLine.d90.s8|98-100|+/|drug_n
DDI-MedLine.d90.s8|130-139|gentamyci|drug
DDI-MedLine.d90.s9|44-46|+/|drug_n
DDI-MedLine.d90.s9|79-81|+/|drug_n
DDI-MedLine.d90.s9|106-115|gentamyci|drug
DDI-MedLine.d90.s10|0-7|Reversa|brand
DDI-MedLine.d90.s11|32-41|gentamyci|drug
DDI-MedLine.d67.s0|0-5|Effec|brand
DDI-MedLine.d67.s0|23-31|midazola|drug
DDI-MedLine.d67.s1|17-25|midazola|drug
DDI-MedLine.d67.s1|184-193|tail-flic|drug_n
DDI-MedLine.d67.s1|199-207|hot-plat|drug_n
DDI-MedLine.d67.s1|209-213|test|group
DDI-MedLine.d67.s3|0-14|Benzodiazepine|brand
DDI-MedLine.d67.s4|0-10|Measuremen|brand
DDI-MedLine.d67.s4|58-71|benzodiazepin|drug
DDI-MedLine.d67.s5|0-7|Diazepa|brand
DDI-MedLine.d67.s6|0-8|Similarl|brand
DDI-MedLine.d67.s6|83-92|tail-flic|drug_n
DDI-MedLine.d67.s7|0-8|Midazola|drug
DDI-MedLine.d67.s7|125-134|tail-flic|drug_n
DDI-MedLine.d106.s0|0-7|Clinica|brand
DDI-MedLine.d106.s0|25-32|warfari|drug
DDI-MedLine.d106.s1|190-197|patient|group
DDI-MedLine.d106.s2|0-3|Eac|brand
DDI-MedLine.d106.s2|60-67|warfari|drug
DDI-MedLine.d106.s2|91-94|pre|drug_n
DDI-MedLine.d106.s3|0-10|Prothrombi|brand
DDI-MedLine.d106.s3|62-70|long-ter|drug_n
DDI-MedLine.d106.s3|72-82|experiment|group
DDI-MedLine.d106.s4|0-12|Anticoagulan|brand
DDI-MedLine.d106.s6|0-11|Barbiturate|brand
DDI-MedLine.d106.s6|60-67|patient|group
DDI-MedLine.d106.s8|0-6|Chlora|brand
DDI-MedLine.d106.s8|99-104|agent|group
DDI-MedLine.d112.s0|0-5|Effec|brand
DDI-MedLine.d112.s0|29-44|pharmacokinetic|group
DDI-MedLine.d112.s0|49-55|digoxi|drug
DDI-MedLine.d112.s1|32-43|steady-stat|drug_n
DDI-MedLine.d112.s1|45-60|pharmacokinetic|group
DDI-MedLine.d112.s1|65-71|digoxi|drug
DDI-MedLine.d112.s1|104-115|double-blin|drug_n
DDI-MedLine.d112.s2|0-3|Fiv|brand
DDI-MedLine.d112.s2|63-74|steady-stat|drug_n
DDI-MedLine.d112.s2|105-111|digoxi|drug
DDI-MedLine.d112.s3|71-77|digoxi|drug
DDI-MedLine.d112.s3|108-114|digoxi|drug
DDI-MedLine.d102.s0|0-8|Influenc|brand
DDI-MedLine.d102.s4|112-133|concentration-respons|drug_n
DDI-MedLine.d102.s5|0-5|Aorti|brand
DDI-MedLine.d102.s5|46-54|high-dos|drug_n
DDI-MedLine.d102.s5|150-157|low-dos|drug_n
DDI-MedLine.d102.s5|209-219|7.86+/-0.0|drug_n
DDI-MedLine.d102.s5|222-232|7.30+/-0.1|drug_n
DDI-MedLine.d102.s5|238-248|7.35+/-0.0|drug_n
DDI-MedLine.d102.s6|0-17|Endothelium-intac|brand
DDI-MedLine.d102.s6|37-50|high-estradio|drug_n
DDI-MedLine.d102.s6|111-118|vehicle|drug_n
DDI-MedLine.d102.s6|121-133|progesterone|drug_n
DDI-MedLine.d102.s6|154-175|high-estradiol-treate|drug_n
DDI-MedLine.d102.s6|196-206|7.77+/-0.1|drug_n
DDI-MedLine.d102.s6|209-219|7.21+/-0.1|drug_n
DDI-MedLine.d102.s6|222-232|6.93+/-0.0|drug_n
DDI-MedLine.d102.s6|238-248|7.22+/-0.1|drug_n
DDI-MedLine.d102.s7|0-4|Ther|brand
DDI-MedLine.d102.s8|0-3|Bot|brand
DDI-MedLine.d102.s8|27-47|endothelium-dependen|drug_n
DDI-MedLine.d84.s0|0-12|Antimicrobia|brand
DDI-MedLine.d84.s0|26-34|Ganoderm|brand
DDI-MedLine.d84.s0|87-97|antibiotic|group
DDI-MedLine.d84.s1|0-12|Antimicrobia|brand
DDI-MedLine.d84.s1|26-27|G|drug_n
DDI-MedLine.d84.s1|74-82|Ganoderm|brand
DDI-MedLine.d84.s1|93-94|F|drug_n
DDI-MedLine.d84.s1|96-100|KARS|brand
DDI-MedLine.d84.s1|131-134|Gra|brand
DDI-MedLine.d84.s1|149-152|Gra|brand
DDI-MedLine.d84.s1|287-289|MI|drug_n
DDI-MedLine.d84.s2|0-4|Amon|brand
DDI-MedLine.d84.s2|72-73|G|drug_n
DDI-MedLine.d84.s2|103-113|Micrococcu|brand
DDI-MedLine.d84.s2|123-125|MI|drug_n
DDI-MedLine.d84.s3|60-61|G|drug_n
DDI-MedLine.d84.s3|82-92|antibiotic|group
DDI-MedLine.d84.s3|203-206|FIC|brand
DDI-MedLine.d84.s4|34-35|G|drug_n
DDI-MedLine.d84.s4|47-57|antibiotic|group
DDI-MedLine.d84.s5|0-8|Synergis|brand
DDI-MedLine.d84.s5|28-29|G|drug_n
DDI-MedLine.d84.s5|67-74|Bacillu|brand
DDI-MedLine.d84.s5|76-83|subtili|group
DDI-MedLine.d84.s5|89-98|Klebsiell|brand
DDI-MedLine.d77.s0|0-6|Effect|brand
DDI-MedLine.d77.s0|51-64|non-myelinate|drug_n
DDI-MedLine.d77.s0|75-89|post-ganglioni|drug_n
DDI-MedLine.d77.s1|67-80|non-myelinate|drug_n
DDI-MedLine.d77.s1|209-214|Eagle|brand
DDI-MedLine.d77.s2|14-14||drug_n
DDI-MedLine.d77.s2|20-33|non-myelinate|drug_n
DDI-MedLine.d77.s2|74-78|S.E.|brand
DDI-MedLine.d77.s4|0-4|Afte|brand
DDI-MedLine.d77.s4|30-30||drug_n
DDI-MedLine.d77.s4|82-86|S.E.|brand
DDI-MedLine.d77.s6|0-3|Thi|brand
DDI-MedLine.d77.s8|55-57|D2|drug_n
DDI-MedLine.d77.s9|0-7|Reforme|brand
DDI-MedLine.d132.s0|22-35|non-nucleosid|drug_n
DDI-MedLine.d132.s0|59-68|inhibitor|group
DDI-MedLine.d132.s1|27-40|non-nucleosid|drug_n
DDI-MedLine.d132.s1|75-79|NNRT|brand
DDI-MedLine.d132.s1|81-86|-base|drug_n
DDI-MedLine.d132.s1|167-168|P|drug_n
DDI-MedLine.d132.s1|170-177|-relate|drug_n
DDI-MedLine.d132.s1|259-261|HI|drug_n
DDI-MedLine.d132.s2|0-10|NNRTI-base|brand
DDI-MedLine.d132.s2|54-61|PI-base|brand
DDI-MedLine.d132.s3|82-87|agent|group
DDI-MedLine.d132.s4|0-3|Bot|brand
DDI-MedLine.d132.s4|76-77|P|drug_n
DDI-MedLine.d132.s4|79-87|indinavi|drug
DDI-MedLine.d132.s5|0-0||drug_n
DDI-MedLine.d132.s5|10-16|24-wee|drug_n
DDI-MedLine.d132.s5|72-73|P|drug_n
DDI-MedLine.d132.s5|75-84|nelfinavi|drug
DDI-MedLine.d132.s6|0-6|Limite|brand
DDI-MedLine.d132.s6|28-35|patient|group
DDI-MedLine.d132.s6|72-82|nevirapine|drug_n
DDI-MedLine.d132.s6|87-103|delavirdine-base|drug_n
DDI-MedLine.d132.s7|0-6|Howeve|brand
DDI-MedLine.d132.s7|99-106|PI-base|brand
DDI-MedLine.d132.s7|126-133|patient|group
DDI-MedLine.d132.s8|34-48|indinavir-base|drug_n
DDI-MedLine.d132.s8|112-119|patient|group
DDI-MedLine.d132.s9|3-23|treatment-experience|drug_n
DDI-MedLine.d132.s9|25-32|patient|group
DDI-MedLine.d132.s9|77-82|agent|group
DDI-MedLine.d132.s9|118-125|NNRTI-n|brand
DDI-MedLine.d132.s9|132-152|treatment-experience|drug_n
DDI-MedLine.d132.s9|154-161|patient|group
DDI-MedLine.d132.s10|0-8|Efaviren|brand
DDI-MedLine.d132.s10|44-53|nelfinavi|drug
DDI-MedLine.d132.s10|58-79|nucleoside-experience|drug_n
DDI-MedLine.d132.s10|81-88|patient|group
DDI-MedLine.d132.s10|118-123|agent|group
DDI-MedLine.d132.s11|20-25|NNRTI|brand
DDI-MedLine.d132.s11|133-138|event|group
DDI-MedLine.d132.s12|24-29|event|group
DDI-MedLine.d132.s12|36-41|NNRTI|brand
DDI-MedLine.d4.s0|45-58|mixed-functio|drug_n
DDI-MedLine.d4.s0|60-72|mono-oxidase|drug_n
DDI-MedLine.d4.s0|135-136|-|drug_n
DDI-MedLine.d4.s0|156-157|-|drug_n
DDI-MedLine.d4.s1|83-99|7-ethoxycoumarin|drug_n
DDI-MedLine.d4.s1|120-125|Wista|brand
DDI-MedLine.d4.s1|153-163|experiment|group
DDI-MedLine.d4.s2|0-3|Whe|brand
DDI-MedLine.d4.s2|109-123|hexanal-induce|drug_n
DDI-MedLine.d120.s0|0-8|Molecula|brand
DDI-MedLine.d120.s0|59-59||drug_n
DDI-MedLine.d120.s1|0-4|Amon|brand
DDI-MedLine.d120.s1|18-28|antibiotic|group
DDI-MedLine.d120.s2|13-13||drug_n
DDI-MedLine.d120.s3|0-3|Bot|brand
DDI-MedLine.d120.s3|71-71||drug_n
DDI-MedLine.d120.s3|178-188|antibiotic|group
DDI-MedLine.d120.s4|78-78||drug_n
DDI-MedLine.d120.s5|164-164||drug_n
DDI-MedLine.d11.s0|0-16|Immunosuppressiv|brand
DDI-MedLine.d11.s1|0-4|Drug|brand
DDI-MedLine.d11.s2|0-3|The|brand
DDI-MedLine.d11.s2|34-41|patient|group
DDI-MedLine.d11.s2|54-64|transplant|group
DDI-MedLine.d11.s3|0-6|Becaus|brand
DDI-MedLine.d11.s3|144-151|patient|group
DDI-MedLine.d11.s3|220-233|non-specialis|drug_n
DDI-MedLine.d11.s4|0-3|Thi|brand
DDI-MedLine.d11.s4|132-147|cyclophosphamid|drug
DDI-MedLine.d11.s4|172-184|non-infectio|drug_n
DDI-MedLine.d15.s0|1-11|Stimulatio|brand
DDI-MedLine.d15.s0|24-25|-|drug_n
DDI-MedLine.d15.s0|70-71|-|drug_n
DDI-MedLine.d15.s0|75-89|3H-spiroperido|drug_n
DDI-MedLine.d15.s0|109-117|long-ter|drug_n
DDI-MedLine.d15.s0|137-148|neuroleptic|group
DDI-MedLine.d15.s0|179-189|experiment|group
DDI-MedLine.d15.s0|368-382|3H-spiroperido|drug_n
DDI-MedLine.d15.s0|466-480|3H-spiroperido|drug_n
DDI-MedLine.d15.s1|0-4|Afte|brand
DDI-MedLine.d15.s1|34-45|neuroleptic|group
DDI-MedLine.d15.s1|164-178|3H-spiroperido|drug_n
DDI-MedLine.d15.s2|49-63|3H-spiroperido|drug_n
DDI-MedLine.d15.s2|116-125|dopamine2|drug_n
DDI-MedLine.d15.s2|131-150|serotonin2-receptor|group
DDI-MedLine.d15.s2|190-201|neuroleptic|group
DDI-MedLine.d15.s3|0-14|Cholecystokini|brand
DDI-MedLine.d15.s3|84-95|neuroleptic|group
DDI-MedLine.d20.s0|0-10|Interactio|brand
DDI-MedLine.d20.s1|75-86|co-activato|drug_n
DDI-MedLine.d20.s1|119-122|NMD|brand
DDI-MedLine.d20.s1|124-132|receptor|group
DDI-MedLine.d20.s4|188-197|17-day-ol|drug_n
DDI-MedLine.d20.s5|0-3|Thi|brand
DDI-MedLine.d20.s6|3-12|13-day-ol|drug_n
DDI-MedLine.d20.s7|173-182|NMDA-ergi|brand
DDI-MedLine.d127.s0|0-4|Seru|brand
DDI-MedLine.d127.s0|6-12|digoxi|drug
DDI-MedLine.d127.s0|30-42|125I-labelle|drug_n
DDI-MedLine.d127.s0|53-62|Validatio|brand
DDI-MedLine.d127.s0|102-109|patient|group
DDI-MedLine.d127.s2|0-13|Determination|brand
DDI-MedLine.d127.s2|24-30|digoxi|drug
DDI-MedLine.d127.s2|85-97|125I-labelle|drug_n
DDI-MedLine.d127.s2|178-188|3H-labelle|drug_n
DDI-MedLine.d127.s4|54-60|digoxi|drug
DDI-MedLine.d127.s6|0-12|Concomitantl|brand
DDI-MedLine.d127.s6|29-37|diuretic|group
DDI-MedLine.d127.s6|92-98|digoxi|drug
DDI-MedLine.d127.s10|0-6|Maxima|brand
DDI-MedLine.d127.s10|62-69|patient|group
DDI-MedLine.d127.s10|111-117|digoxi|drug
DDI-MedLine.d54.s0|0-10|Cholinergi|brand
DDI-MedLine.d54.s0|20-26|alcoho|drug
DDI-MedLine.d54.s1|0-5|Photi|brand
DDI-MedLine.d54.s2|0-4|Sinc|brand
DDI-MedLine.d54.s2|30-39|component|group
DDI-MedLine.d54.s2|151-157|alcoho|drug
DDI-MedLine.d54.s2|168-177|component|group
DDI-MedLine.d54.s2|228-234|alcoho|drug
DDI-MedLine.d54.s3|85-86|I|drug_n
DDI-MedLine.d54.s4|0-6|Ethano|brand
DDI-MedLine.d54.s4|58-67|component|group
DDI-MedLine.d54.s5|0-8|Componen|brand
DDI-MedLine.d54.s5|10-11|P|drug_n
DDI-MedLine.d54.s6|0-12|Physostigmin|brand
DDI-MedLine.d54.s6|52-61|component|group
DDI-MedLine.d54.s6|74-75|P|drug_n
DDI-MedLine.d54.s7|50-59|component|group
DDI-MedLine.d54.s7|61-62|P|drug_n
DDI-MedLine.d54.s7|68-69|P|drug_n
DDI-MedLine.d54.s7|89-98|component|group
DDI-MedLine.d54.s7|100-101|N|drug_n
DDI-MedLine.d54.s7|104-105|N|drug_n
DDI-MedLine.d54.s7|111-112|N|drug_n
DDI-MedLine.d54.s8|0-12|Physostigmin|brand
DDI-MedLine.d54.s8|62-68|alcoho|drug
DDI-MedLine.d54.s8|83-92|component|group
DDI-MedLine.d54.s8|94-95|P|drug_n
DDI-MedLine.d54.s8|101-102|N|drug_n
DDI-MedLine.d54.s8|123-129|alcoho|drug
DDI-MedLine.d54.s8|146-155|component|group
DDI-MedLine.d54.s8|157-158|P|drug_n
DDI-MedLine.d54.s8|164-165|P|drug_n
DDI-MedLine.d54.s9|0-11|Pretreatmen|brand
DDI-MedLine.d54.s9|70-79|component|group
DDI-MedLine.d54.s9|81-82|P|drug_n
DDI-MedLine.d54.s9|88-89|N|drug_n
DDI-MedLine.d54.s9|135-136|N|drug_n
DDI-MedLine.d54.s10|0-7|Atropin|brand
DDI-MedLine.d54.s10|46-52|alcoho|drug
DDI-MedLine.d54.s10|122-123|P|drug_n
DDI-MedLine.d54.s11|42-47|agent|group
DDI-MedLine.d54.s11|109-118|component|group
DDI-MedLine.d54.s11|131-132|N|drug_n
DDI-MedLine.d54.s12|84-85|P|drug_n
DDI-MedLine.d66.s0|0-6|Change|brand
DDI-MedLine.d66.s2|65-70|exist|group
DDI-MedLine.d66.s2|149-170|levonorgestrel-treate|drug_n
DDI-MedLine.d66.s4|0-3|Als|brand
DDI-MedLine.d66.s4|74-77|HPL|brand
DDI-MedLine.d66.s4|161-181|sulphydryl-containin|drug_n
DDI-MedLine.d66.s4|239-241|TL|drug_n
DDI-MedLine.d14.s0|1-1||drug_n
DDI-MedLine.d14.s0|91-97|Chroni|brand
DDI-MedLine.d14.s0|99-109|experiment|group
DDI-MedLine.d14.s0|219-231|pentagastrin|drug_n
DDI-MedLine.d14.s0|237-253|histamine-induce|drug_n
DDI-MedLine.d14.s1|113-121|histamin|drug
DDI-MedLine.d14.s2|0-10|Comparativ|brand
DDI-MedLine.d14.s2|69-76|cholino|drug_n
DDI-MedLine.d14.s2|82-96|adrenoreceptor|group
DDI-MedLine.d107.s0|0-10|Interactio|brand
DDI-MedLine.d107.s0|19-30|constituent|group
DDI-MedLine.d107.s1|0-5|Littl|brand
DDI-MedLine.d107.s1|115-123|congener|group
DDI-MedLine.d107.s1|161-168|content|group
DDI-MedLine.d107.s2|0-5|Twent|brand
DDI-MedLine.d107.s2|17-22|Wista|brand
DDI-MedLine.d107.s3|12-16|SH/D|brand
DDI-MedLine.d107.s3|19-23|SH/F|brand
DDI-MedLine.d107.s4|17-21|SH/E|brand
DDI-MedLine.d107.s9|0-4|Thes|brand
DDI-MedLine.d107.s9|114-122|congener|group
DDI-MedLine.d105.s0|0-3|Lac|brand
DDI-MedLine.d105.s0|21-32|azithromyci|drug
DDI-MedLine.d105.s0|89-100|HIV-infecte|brand
DDI-MedLine.d105.s0|102-109|patient|group
DDI-MedLine.d105.s1|30-41|HIV-infecte|brand
DDI-MedLine.d105.s1|80-91|azithromyci|drug
DDI-MedLine.d105.s2|0-3|Bot|brand
DDI-MedLine.d105.s3|56-67|azithromyci|drug
DDI-MedLine.d105.s3|119-122|Day|brand
DDI-MedLine.d105.s3|137-142|21-da|drug_n
DDI-MedLine.d105.s4|0-7|Subject|brand
DDI-MedLine.d105.s4|91-102|azithromyci|drug
DDI-MedLine.d105.s4|147-150|Day|brand
DDI-MedLine.d105.s5|0-13|Antiretrovira|brand
DDI-MedLine.d105.s5|59-62|Day|brand
DDI-MedLine.d105.s5|99-102|Day|brand
DDI-MedLine.d105.s6|0-9|Periphera|brand
DDI-MedLine.d105.s7|0-11|Azithromyci|drug
DDI-MedLine.d105.s7|46-49|Cma|brand
DDI-MedLine.d105.s7|55-57|AU|drug_n
DDI-MedLine.d105.s8|0-11|Azithromyci|drug
DDI-MedLine.d105.s8|57-72|pharmacokinetic|group
DDI-MedLine.d105.s9|0-4|Base|brand
DDI-MedLine.d105.s9|60-71|azithromyci|drug
DDI-MedLine.d73.s0|0-12|Neurochemica|brand
DDI-MedLine.d73.s0|52-95|1-methyl-4-phenyl-1,2,5,6-tetrahydropyridin|drug
DDI-MedLine.d73.s0|98-101|MPT|brand
DDI-MedLine.d73.s0|108-122|methamphetamin|drug
DDI-MedLine.d73.s1|56-59|MPT|brand
DDI-MedLine.d73.s1|144-158|methamphetamin|drug
DDI-MedLine.d73.s2|21-24|MPT|brand
DDI-MedLine.d73.s2|70-77|dopamin|drug
DDI-MedLine.d73.s3|4-15|MPTP-induce|brand
DDI-MedLine.d73.s3|83-93|amphetamin|drug
DDI-MedLine.d73.s4|0-14|Methamphetamin|drug
DDI-MedLine.d73.s4|22-25|MPT|brand
DDI-MedLine.d73.s4|60-67|dopamin|drug
DDI-MedLine.d73.s5|0-4|Thes|brand
DDI-MedLine.d73.s5|123-130|patient|group
DDI-MedLine.d73.s5|137-145|Parkinso|brand
DDI-MedLine.d73.s5|149-155|Diseas|brand
DDI-MedLine.d131.s0|0-10|Interactio|brand
DDI-MedLine.d131.s1|118-142|D-Ala2-metenkephalinamid|drug
DDI-MedLine.d131.s2|0-14|Antinociceptio|brand
DDI-MedLine.d131.s2|36-44|hot-plat|drug_n
DDI-MedLine.d131.s4|46-53|agonist|group
DDI-MedLine.d75.s0|0-11|Interferenc|brand
DDI-MedLine.d75.s0|30-42|opioid-evoke|drug_n
DDI-MedLine.d75.s1|31-40|whole-cel|drug_n
DDI-MedLine.d75.s1|238-245|agonist|group
DDI-MedLine.d75.s2|0-8|Therefor|brand
DDI-MedLine.d75.s2|118-127|whole-cel|drug_n
DDI-MedLine.d75.s3|44-46|mu|drug_n
DDI-MedLine.d75.s3|57-57||drug_n
DDI-MedLine.d75.s3|64-78|kappa-selectiv|drug_n
DDI-MedLine.d75.s5|0-6|Howeve|brand
DDI-MedLine.d75.s5|102-109|0.05-0.|drug_n
DDI-MedLine.d75.s6|0-6|Restin|brand
DDI-MedLine.d75.s6|186-193|0.05-0.|drug_n
DDI-MedLine.d75.s7|0-4|Thes|brand
DDI-MedLine.d75.s8|0-6|Becaus|brand
DDI-MedLine.d75.s8|67-76|whole-cel|drug_n
DDI-MedLine.d34.s0|0-11|Interaction|brand
DDI-MedLine.d34.s1|183-190|element|group
DDI-MedLine.d34.s2|0-8|Retentio|brand
DDI-MedLine.d34.s3|0-4|Afte|brand
DDI-MedLine.d34.s3|58-65|element|group
DDI-MedLine.d34.s3|104-113|treatment|group
DDI-MedLine.d34.s4|0-5|Cobal|brand
DDI-MedLine.d34.s7|0-9|Additiona|brand
DDI-MedLine.d34.s7|88-97|treatment|group
DDI-MedLine.d34.s9|0-11|Consequentl|brand
DDI-MedLine.d34.s10|0-3|Thi|brand
DDI-MedLine.d34.s10|5-12|suggest|group
DDI-MedLine.d34.s10|48-55|element|group
DDI-MedLine.d34.s11|0-6|Becaus|brand
DDI-MedLine.d34.s11|72-79|content|group
DDI-MedLine.d34.s12|0-10|Difference|brand
DDI-MedLine.d34.s12|193-200|ABSTRAC|brand
DDI-MedLine.d34.s12|202-210|TRUNCATE|brand
DDI-MedLine.d34.s12|212-213|A|drug_n
DDI-MedLine.d34.s12|219-223|WORD|brand
DDI-MedLine.d83.s0|0-9|Olanzapin|brand
DDI-MedLine.d83.s1|0-9|Olanzapin|brand
DDI-MedLine.d83.s1|14-33|thienobenzodiazepin|drug
DDI-MedLine.d83.s2|0-7|Compare|brand
DDI-MedLine.d83.s2|27-40|antipsychotic|group
DDI-MedLine.d83.s2|81-86|5-HT2|drug_n
DDI-MedLine.d83.s2|97-104|dopamin|drug
DDI-MedLine.d83.s2|106-107|D|drug_n
DDI-MedLine.d83.s2|109-117|receptor|group
DDI-MedLine.d83.s3|36-43|patient|group
DDI-MedLine.d83.s3|180-191|improvement|group
DDI-MedLine.d83.s4|4-9|1-yea|drug_n
DDI-MedLine.d83.s5|13-24|double-blin|drug_n
DDI-MedLine.d83.s5|45-51|28-wee|drug_n
DDI-MedLine.d83.s6|41-46|8-wee|drug_n
DDI-MedLine.d83.s6|251-256|agent|group
DDI-MedLine.d83.s7|0-11|Improvement|brand
DDI-MedLine.d83.s7|79-84|1-yea|drug_n
DDI-MedLine.d83.s7|106-113|patient|group
DDI-MedLine.d83.s7|120-130|early-phas|drug_n
DDI-MedLine.d83.s8|0-6|Howeve|brand
DDI-MedLine.d83.s8|37-42|8-wee|drug_n
DDI-MedLine.d83.s8|139-146|patient|group
DDI-MedLine.d83.s9|0-6|Severa|brand
DDI-MedLine.d83.s10|0-9|Olanzapin|brand
DDI-MedLine.d83.s11|190-191|Q|drug_n
DDI-MedLine.d83.s13|44-49|event|group
DDI-MedLine.d83.s13|124-131|patient|group
DDI-MedLine.d83.s14|83-87|cost|group
DDI-MedLine.d83.s15|0-15|Pharmacoeconomi|brand
DDI-MedLine.d83.s15|136-140|cost|group
DDI-MedLine.d83.s16|0-7|Compare|brand
DDI-MedLine.d83.s16|91-95|cost|group
DDI-MedLine.d83.s16|110-121|several-fol|drug_n
DDI-MedLine.d83.s17|0-9|Olanzapin|brand
DDI-MedLine.d83.s17|49-56|patient|group
DDI-MedLine.d83.s18|0-10|CONCLUSION|brand
DDI-MedLine.d83.s18|13-22|Olanzapin|brand
DDI-MedLine.d83.s18|171-178|patient|group
DDI-MedLine.d83.s18|185-197|first-episod|drug_n
DDI-MedLine.d83.s18|202-220|treatment-resistan|drug_n
DDI-MedLine.d83.s19|28-33|event|group
DDI-MedLine.d83.s19|196-205|first-lin|drug_n
DDI-MedLine.d0.s0|27-35|phenytoi|drug
DDI-MedLine.d0.s0|59-70|steady-stat|drug_n
DDI-MedLine.d0.s0|72-87|pharmacokinetic|group
DDI-MedLine.d0.s1|0-9|Quetiapin|brand
DDI-MedLine.d0.s2|59-62|P45|brand
DDI-MedLine.d0.s2|64-66|3A|drug_n
DDI-MedLine.d0.s3|0-8|Therefor|brand
DDI-MedLine.d0.s3|103-118|pharmacokinetic|group
DDI-MedLine.d0.s4|0-3|Thi|brand
DDI-MedLine.d0.s4|51-54|P45|brand
DDI-MedLine.d0.s4|56-69|enzyme-induce|drug_n
DDI-MedLine.d0.s4|71-79|phenytoi|drug
DDI-MedLine.d0.s4|161-166|5-fol|drug_n
DDI-MedLine.d0.s4|225-232|patient|group
DDI-MedLine.d0.s4|239-254|DSM-IV-diagnose|brand
DDI-MedLine.d0.s5|0-4|Thes|brand
DDI-MedLine.d0.s5|232-235|P45|brand
DDI-MedLine.d0.s5|237-239|3A|drug_n
DDI-MedLine.d138.s0|0-10|Interactio|brand
DDI-MedLine.d138.s1|0-10|Interactio|brand
DDI-MedLine.d138.s2|0-9|Inhibitio|brand
DDI-MedLine.d69.s0|0-11|Differentia|brand
DDI-MedLine.d69.s0|70-84|contortrostati|drug
DDI-MedLine.d69.s0|141-150|echistati|drug
DDI-MedLine.d69.s1|28-42|contortrostati|drug
DDI-MedLine.d69.s1|96-105|echistati|drug
DDI-MedLine.d69.s2|21-35|contortrostati|drug
DDI-MedLine.d69.s2|121-123|T2|drug_n
DDI-MedLine.d69.s2|227-233|120-14|drug_n
DDI-MedLine.d69.s3|0-9|Echistati|drug
DDI-MedLine.d69.s3|62-64|T2|drug_n
DDI-MedLine.d69.s3|77-92|dose-dependentl|drug_n
DDI-MedLine.d69.s3|118-132|contortrostati|drug
DDI-MedLine.d69.s4|0-4|Amon|brand
DDI-MedLine.d69.s4|72-86|contortrostati|drug
DDI-MedLine.d69.s4|101-103|CA|drug_n
DDI-MedLine.d69.s5|0-9|Flavoridi|brand
DDI-MedLine.d69.s5|48-50|CA|drug_n
DDI-MedLine.d69.s5|78-100|contortrostatin-induce|drug_n
DDI-MedLine.d69.s5|137-146|MDA-MB-43|brand
DDI-MedLine.d69.s6|0-4|Thes|brand
DDI-MedLine.d69.s6|70-84|contortrostati|drug
DDI-MedLine.d69.s6|137-143|member|group
DDI-MedLine.d135.s0|0-11|Combination|brand
DDI-MedLine.d135.s0|30-42|phencyclidin|drug
DDI-MedLine.d135.s1|0-12|Phencyclidin|drug
DDI-MedLine.d135.s1|15-17|PC|drug_n
DDI-MedLine.d135.s2|73-83|researcher|group
DDI-MedLine.d135.s2|133-143|PCP-induce|brand
DDI-MedLine.d135.s2|145-153|behavior|group
DDI-MedLine.d135.s3|108-110|PC|drug_n
DDI-MedLine.d135.s3|115-123|two-leve|drug_n
DDI-MedLine.d135.s3|155-175|signalled-unsignalle|drug_n
DDI-MedLine.d135.s3|177-215|differential-reinforcement-of-low-rate|drug_n
DDI-MedLine.d135.s3|218-220|DR|drug_n
DDI-MedLine.d135.s4|0-2|PC|drug_n
DDI-MedLine.d135.s4|87-89|PC|drug_n
DDI-MedLine.d135.s4|237-239|DR|drug_n
DDI-MedLine.d135.s5|0-4|Acut|brand
DDI-MedLine.d135.s5|70-72|PC|drug_n
DDI-MedLine.d135.s6|0-4|Thes|brand
DDI-MedLine.d135.s6|72-80|behavior|group
DDI-MedLine.d135.s6|111-113|PC|drug_n
DDI-MedLine.d135.s7|0-6|Furthe|brand
DDI-MedLine.d135.s7|55-57|PC|drug_n
DDI-MedLine.d135.s8|0-4|Sinc|brand
DDI-MedLine.d135.s8|61-74|antipsychotic|group
DDI-MedLine.d135.s8|183-185|PC|drug_n
DDI-MedLine.d99.s0|0-10|Fluvoxamin|drug
DDI-MedLine.d99.s0|25-30|CYP2C|brand
DDI-MedLine.d99.s0|63-73|tolbutamid|drug
DDI-MedLine.d99.s1|0-8|OBJECTIV|brand
DDI-MedLine.d99.s1|32-38|examin|drug
DDI-MedLine.d99.s1|64-74|fluvoxamin|drug
DDI-MedLine.d99.s1|80-90|tolbutamid|drug
DDI-MedLine.d99.s1|108-118|fluvoxamin|drug
DDI-MedLine.d99.s1|129-134|CYP2C|brand
DDI-MedLine.d99.s2|0-6|METHOD|brand
DDI-MedLine.d99.s2|92-103|participant|group
DDI-MedLine.d99.s3|10-10||drug_n
DDI-MedLine.d99.s3|17-26|volunteer|group
DDI-MedLine.d99.s3|43-53|tolbutamid|drug
DDI-MedLine.d99.s4|10-10||drug_n
DDI-MedLine.d99.s4|17-26|volunteer|group
DDI-MedLine.d99.s5|0-3|Eac|brand
DDI-MedLine.d99.s5|42-52|fluvoxamin|drug
DDI-MedLine.d99.s5|76-77|-|drug_n
DDI-MedLine.d99.s6|31-41|tolbutamid|drug
DDI-MedLine.d99.s8|0-5|Plasm|brand
DDI-MedLine.d99.s8|24-34|tolbutamid|drug
DDI-MedLine.d99.s8|64-74|tolbutamid|drug
DDI-MedLine.d99.s8|101-120|4-hydroxytolbutamid|drug
DDI-MedLine.d99.s8|126-143|carboxytolbutamid|drug
DDI-MedLine.d99.s8|157-160|HPL|brand
DDI-MedLine.d99.s9|0-6|RESULT|brand
DDI-MedLine.d99.s9|9-14|Durin|brand
DDI-MedLine.d99.s9|31-41|fluvoxamin|drug
DDI-MedLine.d99.s9|131-141|tolbutamid|drug
DDI-MedLine.d99.s9|181-190|volunteer|group
DDI-MedLine.d99.s10|0-4|Ther|brand
DDI-MedLine.d99.s10|110-120|tolbutamid|drug
DDI-MedLine.d99.s11|26-45|4-hydroxytolbutamid|drug
DDI-MedLine.d99.s11|51-68|carboxytolbutamid|drug
DDI-MedLine.d99.s11|179-189|tolbutamid|drug
DDI-MedLine.d99.s11|265-275|tolbutamid|drug
DDI-MedLine.d99.s12|0-3|Thu|brand
DDI-MedLine.d99.s12|69-83|4-hydroxylatio|drug_n
DDI-MedLine.d99.s12|119-129|fluvoxamin|drug
DDI-MedLine.d99.s13|0-9|CONCLUSIO|brand
DDI-MedLine.d99.s13|12-22|Fluvoxamin|drug
DDI-MedLine.d99.s13|51-56|CYP2C|brand
DDI-MedLine.d9.s0|0-15|Pharmacokinetic|brand
DDI-MedLine.d9.s0|20-32|calcium-entr|drug_n
DDI-MedLine.d9.s0|34-41|blocker|group
DDI-MedLine.d9.s1|0-8|Effectiv|brand
DDI-MedLine.d9.s2|0-3|Suc|brand
DDI-MedLine.d9.s2|17-23|assist|group
DDI-MedLine.d9.s3|8-20|calcium-entr|drug_n
DDI-MedLine.d9.s3|31-36|agent|group
DDI-MedLine.d9.s3|59-64|Unite|brand
DDI-MedLine.d9.s3|66-71|State|brand
DDI-MedLine.d9.s3|85-94|nifedipin|drug
DDI-MedLine.d9.s4|0-10|Nonetheles|brand
DDI-MedLine.d9.s5|25-39|characteristic|group
DDI-MedLine.d9.s5|87-96|nifedipin|drug
DDI-MedLine.d9.s5|171-182|requirement|group
DDI-MedLine.d9.s7|0-3|Suc|brand
DDI-MedLine.d9.s7|102-114|calcium-entr|drug_n
DDI-MedLine.d9.s7|116-126|antagonist|group
DDI-MedLine.d53.s0|0-8|Inductio|brand
DDI-MedLine.d53.s0|69-69||drug_n
DDI-MedLine.d53.s1|0-28|1,25-Dihydroxycholecalcifero|drug_n
DDI-MedLine.d53.s1|30-31|D|drug_n
DDI-MedLine.d53.s1|39-40|O|drug_n
DDI-MedLine.d53.s1|42-44|2D|drug_n
DDI-MedLine.d53.s1|81-81||drug_n
DDI-MedLine.d53.s2|19-23|MCF-|brand
DDI-MedLine.d53.s2|56-57|O|drug_n
DDI-MedLine.d53.s2|59-61|2D|drug_n
DDI-MedLine.d53.s3|7-17|experiment|group
DDI-MedLine.d53.s3|76-77|O|drug_n
DDI-MedLine.d53.s3|79-81|2D|drug_n
DDI-MedLine.d53.s3|104-121|4-hydroxytamoxife|drug_n
DDI-MedLine.d53.s3|124-126|TA|drug_n
DDI-MedLine.d53.s3|162-166|MCF-|brand
DDI-MedLine.d53.s4|22-24|TA|drug_n
DDI-MedLine.d53.s4|97-98|O|drug_n
DDI-MedLine.d53.s4|100-102|2D|drug_n
DDI-MedLine.d53.s5|0-7|Combine|brand
DDI-MedLine.d53.s5|29-30|O|drug_n
DDI-MedLine.d53.s5|32-34|2D|drug_n
DDI-MedLine.d53.s5|40-42|TA|drug_n
DDI-MedLine.d53.s5|106-112|marker|group
DDI-MedLine.d53.s6|31-35|MCF-|brand
DDI-MedLine.d53.s6|61-62|O|drug_n
DDI-MedLine.d53.s6|64-66|2D|drug_n
DDI-MedLine.d53.s6|69-78|MCF-7D3Re|brand
DDI-MedLine.d53.s7|0-4|Thes|brand
DDI-MedLine.d53.s7|32-32||drug_n
DDI-MedLine.d53.s7|97-101|MCF-|brand
DDI-MedLine.d53.s7|141-142|O|drug_n
DDI-MedLine.d53.s7|144-146|2D|drug_n
DDI-MedLine.d53.s8|0-8|Treatmen|brand
DDI-MedLine.d53.s8|41-45|MCF-|brand
DDI-MedLine.d53.s8|58-60|TA|drug_n
DDI-MedLine.d53.s9|0-4|Thes|brand
DDI-MedLine.d53.s9|54-58|MCF-|brand
DDI-MedLine.d53.s9|90-107|vitamin-D-mediate|drug_n
DDI-MedLine.d53.s9|137-154|estrogen-dependen|drug_n
DDI-MedLine.d37.s0|0-13|Anticoagulant|brand
DDI-MedLine.d37.s1|0-8|Treatmen|brand
DDI-MedLine.d37.s1|20-27|patient|group
DDI-MedLine.d37.s1|36-49|anticoagulant|group
DDI-MedLine.d37.s2|0-13|Anticoagulant|brand
DDI-MedLine.d37.s3|0-3|Man|brand
DDI-MedLine.d64.s0|0-14|Pharmacologica|brand
DDI-MedLine.d64.s0|53-62|paroxetin|drug
DDI-MedLine.d64.s1|0-9|Depressio|brand
DDI-MedLine.d64.s2|0-3|Wit|brand
DDI-MedLine.d97.s0|3-11|epidemic|group
DDI-MedLine.d97.s0|78-83|Ugand|brand
DDI-MedLine.d97.s0|86-94|1992-199|drug_n
DDI-MedLine.d97.s0|98-102|Sinc|brand
DDI-MedLine.d97.s0|121-136|non-governmenta|drug_n
DDI-MedLine.d97.s0|151-151||drug_n
DDI-MedLine.d97.s0|161-164|San|brand
DDI-MedLine.d97.s0|166-171|Front|brand
DDI-MedLine.d97.s0|259-262|Moy|brand
DDI-MedLine.d97.s0|265-276|North-Ugand|brand
DDI-MedLine.d97.s1|0-6|Betwee|brand
DDI-MedLine.d97.s1|39-46|patient|group
DDI-MedLine.d97.s2|0-4|Sinc|brand
DDI-MedLine.d97.s2|106-109|Jun|brand
DDI-MedLine.d97.s2|115-121|Octobe|brand
DDI-MedLine.d97.s3|70-72|AR|drug_n
DDI-MedLine.d97.s3|119-126|Adjuman|brand
DDI-MedLine.d97.s4|17-19|AR|drug_n
DDI-MedLine.d97.s4|50-57|patient|group
DDI-MedLine.d97.s4|89-94|Augus|brand
DDI-MedLine.d97.s4|105-113|Septembe|brand
DDI-MedLine.d97.s8|0-4|Amon|brand
DDI-MedLine.d97.s8|15-21|factor|group
DDI-MedLine.d97.s8|67-69|AR|drug_n
DDI-MedLine.d97.s8|92-104|thiabendazol|drug
DDI-MedLine.d97.s8|203-210|patient|group
DDI-MedLine.d97.s9|0-4|Thes|brand
DDI-MedLine.d97.s9|42-51|co-factor|group
DDI-MedLine.d97.s9|92-94|AR|drug_n
DDI-MedLine.d97.s10|0-14|Recommendation|brand
DDI-MedLine.d97.s10|59-73|anti-helminthi|drug_n
DDI-MedLine.d97.s10|143-150|patient|group
DDI-MedLine.d113.s0|0-13|Acid-catalyze|brand
DDI-MedLine.d113.s2|0-3|Whe|brand
DDI-MedLine.d113.s3|118-131|benzodiazepin|drug
DDI-MedLine.d113.s3|217-229|3-ethoxylate|drug_n
DDI-MedLine.d113.s4|0-6|Optima|brand
DDI-MedLine.d113.s4|20-27|kinetic|group
DDI-MedLine.d113.s4|69-82|acid-catalyze|drug_n
DDI-MedLine.d113.s5|111-117|alcoho|drug
DDI-MedLine.d113.s5|123-150|3-hydroxy-1,4-benzodiazepin|drug
DDI-MedLine.d113.s6|4-17|acid-catalyze|drug_n
DDI-MedLine.d113.s6|19-30|ethanol-dru|drug_n
DDI-MedLine.d43.s0|0-4|Tumo|brand
DDI-MedLine.d43.s1|0-8|Currentl|brand
DDI-MedLine.d43.s1|44-49|event|group
DDI-MedLine.d43.s1|95-100|tumor|group
DDI-MedLine.d43.s1|114-119|agent|group
DDI-MedLine.d43.s3|0-7|Analyse|brand
DDI-MedLine.d43.s3|113-127|characteristic|group
DDI-MedLine.d43.s3|146-151|tumor|group
DDI-MedLine.d43.s4|0-13|Vesselinovitc|brand
DDI-MedLine.d43.s5|1-6|Cance|brand
DDI-MedLine.d43.s5|8-11|Res|brand
DDI-MedLine.d43.s5|18-26|2003-201|drug_n
DDI-MedLine.d43.s5|126-131|tumor|group
DDI-MedLine.d43.s6|48-55|C57BL/6|brand
DDI-MedLine.d43.s6|100-117|diethylnitrosamin|drug
DDI-MedLine.d43.s7|0-7|C57BL/6|brand
DDI-MedLine.d43.s7|28-34|number|group
DDI-MedLine.d43.s7|71-76|tumor|group
DDI-MedLine.d43.s7|86-91|liver|group
DDI-MedLine.d43.s8|0-5|Tumor|brand
DDI-MedLine.d43.s8|91-98|C57BL/6|brand
DDI-MedLine.d43.s8|100-100||drug_n
DDI-MedLine.d43.s8|102-108|C3H/He|brand
DDI-MedLine.d43.s8|110-111|F|drug_n
DDI-MedLine.d43.s9|0-4|Thes|brand
DDI-MedLine.d47.s0|0-7|Activit|brand
DDI-MedLine.d47.s0|20-21|I|drug_n
DDI-MedLine.d47.s0|53-64|azithromyci|drug
DDI-MedLine.d47.s0|90-104|Cryptosporidiu|brand
DDI-MedLine.d47.s1|13-32|anti-cryptosporidia|drug_n
DDI-MedLine.d47.s1|54-55|I|drug_n
DDI-MedLine.d47.s1|87-98|azithromyci|drug
DDI-MedLine.d47.s2|0-6|Bufori|brand
DDI-MedLine.d47.s2|8-9|I|drug_n
DDI-MedLine.d47.s3|0-7|Moreove|brand
DDI-MedLine.d47.s3|69-80|azithromyci|drug
DDI-MedLine.d47.s4|0-6|Bufori|brand
DDI-MedLine.d47.s4|8-9|I|drug_n
DDI-MedLine.d47.s4|39-53|Cryptosporidiu|brand
DDI-MedLine.d47.s4|107-118|azithromyci|drug
DDI-MedLine.d57.s0|0-8|Analgesi|brand
DDI-MedLine.d57.s0|21-35|antihistaminic|group
DDI-MedLine.d57.s1|83-97|antihistaminic|group
DDI-MedLine.d57.s1|121-126|agent|group
DDI-MedLine.d57.s1|151-159|adjuvant|group
DDI-MedLine.d57.s2|0-4|Thos|brand
DDI-MedLine.d57.s2|51-65|diphenhydramin|drug
DDI-MedLine.d57.s2|95-104|pyrilamin|drug
DDI-MedLine.d57.s2|107-122|phenyltoloxamin|drug
DDI-MedLine.d57.s2|157-170|tripelennamin|drug
DDI-MedLine.d57.s3|47-61|antihistaminic|group
DDI-MedLine.d57.s4|15-22|suggest|group
DDI-MedLine.d57.s4|63-68|exist|group
DDI-MedLine.d57.s5|0-4|Ther|brand
DDI-MedLine.d57.s6|47-54|dopamin|drug
DDI-MedLine.d57.s6|75-89|antihistaminic|group
DDI-MedLine.d57.s7|0-4|Stil|brand
DDI-MedLine.d57.s8|0-0||drug_n
DDI-MedLine.d57.s8|79-93|antihistaminic|group
DDI-MedLine.d44.s0|0-6|Effect|brand
DDI-MedLine.d44.s0|45-60|chylomicron-lik|drug_n
DDI-MedLine.d44.s0|75-82|patient|group
DDI-MedLine.d44.s1|0-3|Slo|brand
DDI-MedLine.d44.s1|124-131|speed-u|drug_n
DDI-MedLine.d44.s2|111-118|kinetic|group
DDI-MedLine.d44.s2|125-140|chylomicron-lik|drug_n
DDI-MedLine.d44.s2|163-170|patient|group
DDI-MedLine.d44.s2|207-213|59+/-1|drug_n
DDI-MedLine.d44.s2|242-249|240+/-4|drug_n
DDI-MedLine.d44.s2|273-280|188+/-4|drug_n
DDI-MedLine.d44.s2|327-338|double-blin|drug_n
DDI-MedLine.d44.s2|341-358|placebo-controlle|drug_n
DDI-MedLine.d44.s2|427-433|1-mont|drug_n
DDI-MedLine.d44.s3|0-0||drug_n
DDI-MedLine.d44.s3|2-8|1-mont|drug_n
DDI-MedLine.d44.s4|0-7|Patient|brand
DDI-MedLine.d44.s4|39-54|chylomicron-lik|drug_n
DDI-MedLine.d44.s4|85-99|14C-cholestery|drug_n
DDI-MedLine.d44.s4|112-122|3H-triolei|drug_n
DDI-MedLine.d44.s4|146-155|treatment|group
DDI-MedLine.d44.s5|0-4|Afte|brand
DDI-MedLine.d44.s5|123-134|high-densit|drug_n
DDI-MedLine.d44.s6|0-9|Etofibrat|brand
DDI-MedLine.d44.s6|39-50|post-hepari|drug_n
DDI-MedLine.d44.s6|92-106|3H-triglycerid|drug_n
DDI-MedLine.d44.s7|0-14|14C-cholestero|drug_n
DDI-MedLine.d44.s8|0-8|Therefor|brand
DDI-MedLine.d128.s0|0-7|Analysi|brand
DDI-MedLine.d128.s0|12-38|16,16-dimethylprostaglandi|drug_n
DDI-MedLine.d128.s0|40-49|E2-induce|brand
DDI-MedLine.d128.s1|4-30|16,16-dimethylprostaglandi|drug_n
DDI-MedLine.d128.s1|32-33|E|drug_n
DDI-MedLine.d128.s1|43-50|-induce|drug_n
DDI-MedLine.d128.s2|8-14|0.1-1.|drug_n
DDI-MedLine.d128.s3|0-15|dose-dependentl|drug_n
DDI-MedLine.d128.s4|18-34|diarrhea-inducin|drug_n
DDI-MedLine.d128.s5|0-3|Whe|brand
DDI-MedLine.d128.s5|144-156|short-lastin|drug_n
DDI-MedLine.d128.s6|0-5|Casto|brand
DDI-MedLine.d128.s8|0-4|Ther|brand
DDI-MedLine.d128.s8|129-136|-induce|drug_n
DDI-MedLine.d128.s8|138-149|enhancement|group
DDI-MedLine.d128.s9|0-7|Moreove|brand
DDI-MedLine.d128.s9|24-37|dmPGE2-induce|drug_n
DDI-MedLine.d128.s9|57-65|transfer|group
DDI-MedLine.d128.s10|151-167|transit-enhancin|drug_n
DDI-MedLine.d128.s11|24-31|content|group
DDI-MedLine.d128.s12|0-9|Loperamid|drug
DDI-MedLine.d128.s13|0-9|Loperamid|drug
DDI-MedLine.d128.s13|88-95|-induce|drug_n
DDI-MedLine.d128.s14|0-19|N-methyllevallorpha|brand
DDI-MedLine.d128.s15|0-19|N-methyllevallorpha|brand
DDI-MedLine.d128.s15|85-94|loperamid|drug
DDI-MedLine.d128.s16|0-4|Thes|brand
DDI-MedLine.d128.s17|0-3|Thi|brand
DDI-MedLine.d60.s0|0-8|Phenytoi|drug
DDI-MedLine.d60.s0|34-44|fluvoxamin|drug
DDI-MedLine.d60.s1|0-0||drug_n
DDI-MedLine.d60.s1|14-22|phenytoi|drug
DDI-MedLine.d60.s1|61-71|fluvoxamin|drug
DDI-MedLine.d60.s2|27-35|phenytoi|drug
DDI-MedLine.d60.s2|93-103|fluvoxamin|drug
DDI-MedLine.d60.s2|154-162|phenytoi|drug
DDI-MedLine.d60.s3|0-5|Durin|brand
DDI-MedLine.d60.s3|7-15|phenytoi|drug
DDI-MedLine.d60.s3|21-31|fluvoxamin|drug
DDI-MedLine.d60.s3|77-85|phenytoi|drug
DDI-MedLine.d60.s4|17-22|CYP2C|brand
DDI-MedLine.d60.s4|28-31|2C1|drug_n
DDI-MedLine.d60.s4|62-70|phenytoi|drug
DDI-MedLine.d60.s4|108-116|wild-typ|drug_n
DDI-MedLine.d60.s4|127-137|CYP2C9*1/*|brand
DDI-MedLine.d60.s4|143-149|2C19*1|drug_n
DDI-MedLine.d60.s5|54-59|CYP2C|brand
DDI-MedLine.d60.s5|65-68|2C1|drug_n
DDI-MedLine.d60.s5|73-83|fluvoxamin|drug
DDI-MedLine.d103.s0|0-8|Magnesiu|brand
DDI-MedLine.d103.s0|14-25|therapeutic|group
DDI-MedLine.d103.s2|0-6|Primar|brand
DDI-MedLine.d103.s4|0-12|Physiologica|brand
DDI-MedLine.d103.s5|0-12|Physiologica|brand
DDI-MedLine.d103.s5|153-169|contra-indicatio|drug_n
DDI-MedLine.d103.s6|0-7|Specifi|brand
DDI-MedLine.d103.s6|23-32|treatment|group
DDI-MedLine.d103.s6|104-112|diuretic|group
DDI-MedLine.d103.s6|148-149|B|drug_n
DDI-MedLine.d103.s6|183-183||drug_n
DDI-MedLine.d103.s8|0-4|Ther|brand
DDI-MedLine.d103.s8|182-183|-|drug_n
DDI-MedLine.d103.s8|219-220|-|drug_n
DDI-MedLine.d103.s9|0-4|Toda|brand
DDI-MedLine.d103.s12|0-8|Magnesiu|brand
DDI-MedLine.d103.s13|0-3|Hig|brand
DDI-MedLine.d103.s14|0-4|Ther|brand
DDI-MedLine.d103.s15|0-5|Lastl|brand
DDI-MedLine.d103.s15|147-157|transplant|group
DDI-MedLine.d3.s0|0-14|Pharmacokineti|brand
DDI-MedLine.d3.s0|16-26|Interactio|brand
DDI-MedLine.d3.s0|36-45|amprenavi|drug
DDI-MedLine.d3.s1|92-101|amprenavi|drug
DDI-MedLine.d3.s1|190-201|erythromyci|drug
DDI-MedLine.d3.s1|216-220|ERMB|brand
DDI-MedLine.d3.s2|0-10|Twenty-fou|brand
DDI-MedLine.d3.s3|22-31|amprenavi|drug
DDI-MedLine.d3.s3|82-86|7-da|drug_n
DDI-MedLine.d3.s3|153-154|Q|drug_n
DDI-MedLine.d3.s3|189-190|Q|drug_n
DDI-MedLine.d3.s4|0-5|Cohor|brand
DDI-MedLine.d3.s4|23-32|amprenavi|drug
DDI-MedLine.d3.s4|84-93|amprenavi|drug
DDI-MedLine.d3.s5|0-5|Seria|brand
DDI-MedLine.d3.s5|51-60|amprenavi|drug
DDI-MedLine.d3.s5|97-110|25-O-desacety|drug_n
DDI-MedLine.d3.s5|142-157|high-performanc|drug_n
DDI-MedLine.d3.s6|0-8|Rifabuti|brand
DDI-MedLine.d3.s6|39-48|amprenavi|drug
DDI-MedLine.d3.s6|52-67|pharmacokinetic|group
DDI-MedLine.d3.s7|0-9|Amprenavi|drug
DDI-MedLine.d3.s7|77-79|AU|drug_n
DDI-MedLine.d3.s7|102-110|2.93-fol|drug_n
DDI-MedLine.d3.s7|120-122|AU|drug_n
DDI-MedLine.d3.s7|131-153|25-O-desacetylrifabuti|drug_n
DDI-MedLine.d3.s7|158-166|13.3-fol|drug_n
DDI-MedLine.d3.s8|0-7|Rifampi|brand
DDI-MedLine.d3.s8|37-39|AU|drug_n
DDI-MedLine.d3.s8|48-57|amprenavi|drug
DDI-MedLine.d3.s8|71-80|amprenavi|drug
DDI-MedLine.d3.s8|108-123|pharmacokinetic|group
DDI-MedLine.d3.s9|0-9|Amprenavi|drug
DDI-MedLine.d3.s9|40-44|ERMB|brand
DDI-MedLine.d3.s10|19-23|ERMB|brand
DDI-MedLine.d3.s11|0-9|Amprenavi|drug
DDI-MedLine.d3.s12|0-9|Amprenavi|drug
DDI-MedLine.d3.s13|0-7|Rifampi|brand
DDI-MedLine.d3.s13|55-64|amprenavi|drug
DDI-MedLine.d3.s14|0-9|Amprenavi|drug
DDI-MedLine.d3.s14|62-84|25-O-desacetylrifabuti|drug_n
DDI-MedLine.d3.s15|0-9|Amprenavi|drug
DDI-MedLine.d3.s15|24-28|ERMB|brand
DDI-MedLine.d3.s15|73-80|inducer|group
DDI-MedLine.d3.s15|89-93|ERMB|brand
DDI-MedLine.d124.s0|0-3|Lac|brand
DDI-MedLine.d124.s0|28-39|levofloxaci|drug
DDI-MedLine.d124.s0|56-71|pharmacokinetic|group
DDI-MedLine.d124.s1|0-7|Previou|brand
DDI-MedLine.d124.s1|90-102|trovafloxaci|drug
DDI-MedLine.d124.s1|108-120|ciprofloxaci|drug
DDI-MedLine.d124.s2|0-3|Thi|brand
DDI-MedLine.d124.s2|59-61|AU|drug_n
DDI-MedLine.d124.s2|67-79|trovafloxaci|drug
DDI-MedLine.d124.s2|85-97|ciprofloxaci|drug
DDI-MedLine.d124.s3|4-10|author|group
DDI-MedLine.d124.s3|88-99|levofloxaci|drug
DDI-MedLine.d124.s4|0-4|Eigh|brand
DDI-MedLine.d124.s4|14-23|volunteer|group
DDI-MedLine.d124.s4|47-56|open-labe|drug_n
DDI-MedLine.d124.s4|59-65|two-wa|drug_n
DDI-MedLine.d124.s5|0-2|Q4|drug_n
DDI-MedLine.d124.s5|9-20|levofloxaci|drug
DDI-MedLine.d124.s6|39-50|levofloxaci|drug
DDI-MedLine.d124.s8|0-4|Bloo|brand
DDI-MedLine.d124.s8|84-87|Cma|brand
DDI-MedLine.d124.s8|100-102|AU|drug_n
DDI-MedLine.d124.s9|0-4|Ther|brand
DDI-MedLine.d124.s9|53-55|AU|drug_n
DDI-MedLine.d124.s9|64-66|+/|drug_n
DDI-MedLine.d124.s9|82-84|+/|drug_n
DDI-MedLine.d124.s9|93-96|Cma|brand
DDI-MedLine.d124.s9|104-106|+/|drug_n
DDI-MedLine.d124.s9|120-122|+/|drug_n
DDI-MedLine.d124.s9|144-146|+/|drug_n
DDI-MedLine.d124.s9|160-162|+/|drug_n
DDI-MedLine.d124.s9|173-184|levofloxaci|drug
DDI-MedLine.d124.s10|41-52|levofloxaci|drug
DDI-MedLine.d124.s10|122-124|AU|drug_n
DDI-MedLine.d124.s10|127-130|Cma|brand
DDI-MedLine.d10.s0|0-5|Herba|brand
DDI-MedLine.d10.s1|67-72|Unite|brand
DDI-MedLine.d10.s1|74-79|State|brand
DDI-MedLine.d10.s2|0-7|Researc|brand
DDI-MedLine.d10.s4|0-7|Patient|brand
DDI-MedLine.d10.s5|0-3|Thi|brand
DDI-MedLine.d10.s5|107-114|patient|group
DDI-MedLine.d137.s0|0-6|Glucos|brand
DDI-MedLine.d137.s1|0-14|AIMS/HYPOTHESI|brand
DDI-MedLine.d137.s1|17-21|Ther|brand
DDI-MedLine.d137.s2|0-4|Ther|brand
DDI-MedLine.d137.s2|152-159|patient|group
DDI-MedLine.d137.s3|0-6|METHOD|brand
DDI-MedLine.d137.s3|38-42|3-wa|drug_n
DDI-MedLine.d137.s5|81-92|somatostati|drug
DDI-MedLine.d137.s7|0-6|RESULT|brand
DDI-MedLine.d137.s7|9-15|Insuli|brand
DDI-MedLine.d137.s8|0-13|Hyperglycaemi|brand
DDI-MedLine.d137.s8|50-59|parameter|group
DDI-MedLine.d137.s9|0-11|Haemodynami|brand
DDI-MedLine.d137.s9|63-74|somatostati|drug
DDI-MedLine.d137.s9|80-94|co-administere|drug_n
DDI-MedLine.d137.s10|0-25|CONCLUSIONS/INTERPRETATIO|brand
DDI-MedLine.d137.s10|28-34|Glucos|brand
DDI-MedLine.d137.s11|120-127|patient|group
DDI-MedLine.d137.s11|134-137|Typ|brand
DDI-MedLine.d137.s11|139-139||drug_n
DDI-MedLine.d137.s11|142-158|insulin-dependen|drug_n
DDI-MedLine.d141.s0|0-7|Toxicit|brand
DDI-MedLine.d141.s0|70-78|Parorchi|brand
DDI-MedLine.d141.s0|90-96|Digene|brand
DDI-MedLine.d141.s0|99-114|Philophthalmida|brand
DDI-MedLine.d141.s1|167-175|Parorchi|brand
DDI-MedLine.d141.s1|214-220|Nucell|brand
DDI-MedLine.d141.s2|0-8|Cercaria|brand
DDI-MedLine.d141.s4|0-7|Mixture|brand
DDI-MedLine.d141.s5|0-9|Excystmen|brand
DDI-MedLine.d141.s6|0-10|Twenty-fou|brand
DDI-MedLine.d141.s6|40-44|cyst|group
DDI-MedLine.d141.s7|0-6|Effect|brand
DDI-MedLine.d141.s7|91-107|cercariae-expose|drug_n
DDI-MedLine.d141.s7|109-109||drug_n
DDI-MedLine.d141.s9|47-58|cyst-expose|drug_n
DDI-MedLine.d100.s0|0-8|Influenc|brand
DDI-MedLine.d100.s0|13-27|calcium-channe|drug_n
DDI-MedLine.d100.s0|29-36|blocker|group
DDI-MedLine.d100.s1|0-8|Availabl|brand
DDI-MedLine.d100.s1|93-99|factor|group
DDI-MedLine.d100.s2|0-5|Plasm|brand
DDI-MedLine.d100.s2|133-140|content|group
DDI-MedLine.d100.s3|0-6|Releas|brand
DDI-MedLine.d100.s3|131-132|A|drug_n
DDI-MedLine.d100.s4|0-8|Adenosin|brand
DDI-MedLine.d100.s4|10-21|3':5'-cycli|drug_n
DDI-MedLine.d100.s4|105-121|calcium-dependen|drug_n
DDI-MedLine.d100.s5|0-11|Slow-channe|brand
DDI-MedLine.d100.s5|21-28|blocker|group
DDI-MedLine.d100.s5|64-73|nifedipin|drug
DDI-MedLine.d100.s6|0-4|Thes|brand
DDI-MedLine.d100.s6|6-11|agent|group
DDI-MedLine.d100.s6|90-91|A|drug_n
DDI-MedLine.d100.s7|0-3|Som|brand
DDI-MedLine.d100.s7|43-50|blocker|group
DDI-MedLine.d100.s8|0-4|Thes|brand
DDI-MedLine.d100.s8|25-32|blocker|group
DDI-MedLine.d100.s8|133-140|patient|group
DDI-MedLine.d5.s0|0-7|Repeate|brand
DDI-MedLine.d5.s1|0-11|Interaction|brand
DDI-MedLine.d5.s1|21-30|treatment|group
DDI-MedLine.d5.s2|0-0||drug_n
DDI-MedLine.d5.s2|134-152|bishydroxy-coumari|drug_n
DDI-MedLine.d5.s2|157-163|wether|group
DDI-MedLine.d5.s3|43-44|I|drug_n
DDI-MedLine.d5.s3|157-160|ACh|brand
DDI-MedLine.d5.s4|77-78|I|drug_n
DDI-MedLine.d5.s5|0-8|Treatmen|brand
DDI-MedLine.d5.s5|126-135|treatment|group
DDI-MedLine.d101.s0|0-11|Pharmacolog|brand
DDI-MedLine.d101.s0|60-67|patient|group
DDI-MedLine.d101.s1|0-13|Cardiovascula|brand
DDI-MedLine.d101.s1|81-88|patient|group
DDI-MedLine.d101.s2|0-3|Dru|brand
DDI-MedLine.d101.s2|17-24|patient|group
DDI-MedLine.d101.s3|95-102|patient|group
DDI-MedLine.d101.s4|0-3|Thi|brand
DDI-MedLine.d101.s4|56-71|pharmacokinetic|group
DDI-MedLine.d101.s5|0-6|Severa|brand
DDI-MedLine.d51.s0|0-6|Effect|brand
DDI-MedLine.d51.s0|95-103|receptor|group
DDI-MedLine.d51.s1|50-60|antagonist|group
DDI-MedLine.d51.s1|73-84|theophyllin|drug
DDI-MedLine.d51.s1|87-106|8-phenyltheophyllin|drug
DDI-MedLine.d51.s1|113-146|8-cyclopentyl-1,3-dipropylxanthin|drug_n
DDI-MedLine.d51.s1|149-153|DPCP|brand
DDI-MedLine.d51.s2|4-14|antagonist|group
DDI-MedLine.d51.s3|26-37|theophyllin|drug
DDI-MedLine.d51.s3|73-75|CG|drug_n
DDI-MedLine.d51.s3|87-98|A2-selectiv|brand
DDI-MedLine.d51.s3|120-142|N6-cyclopentyladenosin|brand
DDI-MedLine.d51.s3|145-147|CP|drug_n
DDI-MedLine.d51.s3|154-165|A1-selectiv|brand
DDI-MedLine.d51.s4|0-6|Howeve|brand
DDI-MedLine.d51.s4|31-50|theophylline-induce|drug_n
DDI-MedLine.d51.s4|74-81|CGS2168|brand
DDI-MedLine.d51.s4|142-154|DPCPX-induce|brand
DDI-MedLine.d51.s4|200-202|CG|drug_n
DDI-MedLine.d51.s4|217-219|CP|drug_n
DDI-MedLine.d51.s5|0-6|Finall|brand
DDI-MedLine.d51.s5|28-43|xanthine-derive|drug_n
DDI-MedLine.d51.s5|55-65|antagonist|group
DDI-MedLine.d51.s6|64-72|receptor|group
DDI-MedLine.d51.s6|101-120|theophylline-induce|drug_n
DDI-MedLine.d51.s6|164-165|A|drug_n
DDI-MedLine.d133.s0|0-10|Suppressio|brand
DDI-MedLine.d133.s0|28-44|bombesin-enhance|drug_n
DDI-MedLine.d133.s1|0-9|BACKGROUN|brand
DDI-MedLine.d133.s1|228-230|AO|drug_n
DDI-MedLine.d133.s1|270-276|cancer|group
DDI-MedLine.d133.s1|304-309|Wista|brand
DDI-MedLine.d133.s2|0-6|METHOD|brand
DDI-MedLine.d133.s2|9-12|Fro|brand
DDI-MedLine.d133.s2|100-102|AO|drug_n
DDI-MedLine.d133.s3|0-6|RESULT|brand
DDI-MedLine.d133.s3|9-16|Bombesi|brand
DDI-MedLine.d133.s3|70-75|tumor|group
DDI-MedLine.d133.s4|0-7|Althoug|brand
DDI-MedLine.d133.s4|257-263|cancer|group
DDI-MedLine.d133.s5|0-8|Verapami|brand
DDI-MedLine.d133.s6|0-9|CONCLUSIO|brand
DDI-MedLine.d133.s6|12-16|Thes|brand
DDI-MedLine.d133.s6|138-144|cancer|group
DDI-MedLine.d32.s0|0-10|Prescribin|brand
DDI-MedLine.d32.s1|0-3|Key|brand
DDI-MedLine.d32.s2|0-3|Whe|brand
DDI-MedLine.d32.s2|27-34|patient|group
DDI-MedLine.d32.s5|0-4|Ther|brand
DDI-MedLine.d32.s5|69-76|patient|group
DDI-MedLine.d32.s6|0-4|Thes|brand
DDI-MedLine.d32.s6|162-167|agent|group
DDI-MedLine.d32.s7|0-4|Clos|brand
DDI-MedLine.d32.s7|142-149|patient|group
DDI-MedLine.d93.s0|0-6|Altere|brand
DDI-MedLine.d93.s0|26-32|alcoho|drug
DDI-MedLine.d93.s1|0-4|Ethy|brand
DDI-MedLine.d93.s1|6-12|alcoho|drug
DDI-MedLine.d93.s1|123-131|behavior|group
DDI-MedLine.d93.s2|0-11|Organometal|brand
DDI-MedLine.d93.s3|0-4|Sinc|brand
DDI-MedLine.d93.s3|11-17|alcoho|drug
DDI-MedLine.d93.s4|0-5|Thirt|brand
DDI-MedLine.d93.s4|24-34|Fischer-34|brand
DDI-MedLine.d93.s4|125-127|TM|drug_n
DDI-MedLine.d93.s4|152-153|S|drug_n
DDI-MedLine.d93.s5|0-7|Fourtee|brand
DDI-MedLine.d93.s5|98-99|I|drug_n
DDI-MedLine.d93.s6|24-30|alcoho|drug
DDI-MedLine.d93.s7|112-128|sound-attenuatin|drug_n
DDI-MedLine.d93.s7|130-137|chamber|group
DDI-MedLine.d93.s8|42-44|TM|drug_n
DDI-MedLine.d93.s9|0-4|Thes|brand
DDI-MedLine.d93.s9|129-135|alcoho|drug
DDI-MedLine.d116.s0|0-7|Rifampi|brand
DDI-MedLine.d116.s0|13-20|warfari|drug
DDI-MedLine.d116.s1|29-36|warfari|drug
DDI-MedLine.d116.s2|0-7|Rifampi|brand
DDI-MedLine.d116.s2|43-50|warfari|drug
DDI-MedLine.d116.s2|52-63|requirement|group
DDI-MedLine.d116.s2|99-104|agent|group
DDI-MedLine.d116.s3|47-54|warfari|drug
DDI-MedLine.d116.s3|119-126|warfari|drug
DDI-MedLine.d116.s4|0-9|Withdrawa|brand
DDI-MedLine.d116.s4|37-44|warfari|drug
DDI-MedLine.d116.s5|0-3|Thi|brand
DDI-MedLine.d116.s5|113-120|warfari|drug
DDI-MedLine.d116.s6|30-37|warfari|drug
DDI-MedLine.d116.s7|0-3|Thi|brand
DDI-MedLine.d78.s1|52-62|antibiotic|group
DDI-MedLine.d78.s1|106-118|gram-negativ|drug_n
DDI-MedLine.d78.s1|129-141|gram-positiv|drug_n
DDI-MedLine.d78.s2|0-4|Thes|brand
DDI-MedLine.d78.s2|6-11|agent|group
DDI-MedLine.d78.s2|24-34|norfloxaci|drug
DDI-MedLine.d78.s2|37-49|ciprofloxaci|drug
DDI-MedLine.d78.s2|52-60|ofloxaci|drug
DDI-MedLine.d78.s2|63-70|enoxaci|drug
DDI-MedLine.d78.s2|77-88|lomefloxaci|drug
DDI-MedLine.d78.s2|213-218|agent|group
DDI-MedLine.d78.s3|0-9|Advantage|brand
DDI-MedLine.d78.s3|36-46|antibiotic|group
DDI-MedLine.d78.s3|64-79|pharmacokinetic|group
DDI-MedLine.d78.s3|104-122|multidrug-resistan|drug_n
DDI-MedLine.d78.s3|180-190|antibiotic|group
DDI-MedLine.d27.s0|5-14|GABA-ergi|brand
DDI-MedLine.d27.s0|242-253|phentolamin|drug
DDI-MedLine.d27.s1|0-3|Whe|brand
DDI-MedLine.d27.s2|0-8|Prolonge|brand
DDI-MedLine.d27.s3|23-35|GABA-positiv|brand
DDI-MedLine.d8.s0|21-28|KRM-164|brand
DDI-MedLine.d8.s0|68-76|ofloxaci|drug
DDI-MedLine.d8.s0|87-99|Mycobacteriu|brand
DDI-MedLine.d8.s1|30-49|benzoxazinorifamyci|drug
DDI-MedLine.d8.s1|52-59|KRM-164|brand
DDI-MedLine.d8.s1|98-106|ofloxaci|drug
DDI-MedLine.d8.s1|186-198|Mycobacteriu|brand
DDI-MedLine.d8.s2|0-5|Growt|brand
DDI-MedLine.d8.s2|10-10||drug_n
DDI-MedLine.d8.s3|31-36|count|group
DDI-MedLine.d8.s3|46-51|BACTE|brand
DDI-MedLine.d8.s4|86-93|KRM-164|brand
DDI-MedLine.d8.s4|103-103||drug_n
DDI-MedLine.d8.s5|120-126|0.1-0.|drug_n
DDI-MedLine.d8.s5|137-143|0.1-0.|drug_n
DDI-MedLine.d8.s6|0-3|Whe|brand
DDI-MedLine.d8.s6|19-27|ofloxaci|drug
DDI-MedLine.d8.s6|30-37|KRM-164|brand
DDI-MedLine.d8.s6|173-181|ofloxaci|drug
DDI-MedLine.d8.s7|0-4|Thes|brand
DDI-MedLine.d8.s7|27-34|KRM-164|brand
DDI-MedLine.d8.s7|78-78||drug_n
DDI-MedLine.d109.s0|0-5|Effec|brand
DDI-MedLine.d109.s0|27-42|pharmacokinetic|group
DDI-MedLine.d109.s0|47-53|digoxi|drug
DDI-MedLine.d109.s0|66-75|volunteer|group
DDI-MedLine.d109.s1|4-10|author|group
DDI-MedLine.d109.s1|39-54|cyclooxygenase-|drug_n
DDI-MedLine.d109.s1|57-61|COX-|brand
DDI-MedLine.d109.s1|109-124|pharmacokinetic|group
DDI-MedLine.d109.s1|129-135|digoxi|drug
DDI-MedLine.d109.s2|0-3|Eac|brand
DDI-MedLine.d109.s2|22-22||drug_n
DDI-MedLine.d109.s2|96-107|double-blin|drug_n
DDI-MedLine.d109.s2|132-141|two-perio|drug_n
DDI-MedLine.d109.s3|0-0||drug_n
DDI-MedLine.d109.s3|29-35|digoxi|drug
DDI-MedLine.d109.s3|84-89|11-da|drug_n
DDI-MedLine.d109.s4|0-3|Eac|brand
DDI-MedLine.d109.s5|0-6|Sample|brand
DDI-MedLine.d109.s5|44-50|digoxi|drug
DDI-MedLine.d109.s5|114-120|digoxi|drug
DDI-MedLine.d109.s6|106-112|digoxi|drug
DDI-MedLine.d109.s6|130-139|parameter|group
DDI-MedLine.d109.s7|4-10|digoxi|drug
DDI-MedLine.d109.s7|12-14|AU|drug_n
DDI-MedLine.d109.s7|16-25|0-infinit|drug_n
DDI-MedLine.d109.s7|29-31|AU|drug_n
DDI-MedLine.d109.s7|33-36|0-2|drug_n
DDI-MedLine.d109.s7|44-47|Cma|brand
DDI-MedLine.d109.s7|137-143|digoxi|drug
DDI-MedLine.d109.s8|4-10|digoxi|drug
DDI-MedLine.d109.s8|47-56|treatment|group
DDI-MedLine.d109.s9|30-38|half-lif|drug_n
DDI-MedLine.d109.s9|80-86|digoxi|drug
DDI-MedLine.d109.s9|102-108|digoxi|drug
DDI-MedLine.d109.s9|110-119|treatment|group
DDI-MedLine.d109.s10|0-6|Digoxi|drug
DDI-MedLine.d109.s11|10-11|S|drug_n
DDI-MedLine.d109.s11|61-67|digoxi|drug
DDI-MedLine.d109.s11|133-135|+/|drug_n
DDI-MedLine.d109.s11|154-156|+/|drug_n
DDI-MedLine.d109.s12|0-8|Transien|brand
DDI-MedLine.d109.s12|28-33|event|group
DDI-MedLine.d109.s12|92-101|treatment|group
DDI-MedLine.d109.s12|111-127|treatment-relate|drug_n
DDI-MedLine.d109.s13|0-8|Rofecoxi|brand
DDI-MedLine.d109.s13|39-54|pharmacokinetic|group
DDI-MedLine.d109.s13|102-108|digoxi|drug
DDI-MedLine.d12.s0|0-12|Dexamethason|brand
DDI-MedLine.d12.s0|66-69|EGF|brand
DDI-MedLine.d12.s0|74-88|insulin-induce|drug_n
DDI-MedLine.d12.s1|0-8|Prostati|brand
DDI-MedLine.d12.s1|81-88|RPMI164|brand
DDI-MedLine.d12.s1|131-133|EG|drug_n
DDI-MedLine.d12.s1|185-189|IU/m|brand
DDI-MedLine.d12.s2|0-7|Althoug|brand
DDI-MedLine.d12.s2|105-112|RPMI164|brand
DDI-MedLine.d12.s2|180-182|EG|drug_n
DDI-MedLine.d12.s3|0-12|Dexamethason|brand
DDI-MedLine.d12.s3|20-22|-1|drug_n
DDI-MedLine.d12.s3|25-25||drug_n
DDI-MedLine.d12.s3|57-57||drug_n
DDI-MedLine.d12.s3|62-63|-|drug_n
DDI-MedLine.d12.s3|66-66||drug_n
DDI-MedLine.d12.s3|105-107|EG|drug_n
DDI-MedLine.d12.s4|0-5|Highe|brand
DDI-MedLine.d12.s4|43-44|-|drug_n
DDI-MedLine.d12.s4|47-47||drug_n
DDI-MedLine.d12.s4|52-53|-|drug_n
DDI-MedLine.d12.s4|56-56||drug_n
DDI-MedLine.d12.s4|81-81||drug_n
DDI-MedLine.d12.s4|86-87|-|drug_n
DDI-MedLine.d12.s4|90-90||drug_n
DDI-MedLine.d12.s4|95-96|-|drug_n
DDI-MedLine.d12.s4|99-99||drug_n
DDI-MedLine.d12.s4|136-138|EG|drug_n
DDI-MedLine.d12.s5|0-12|Dexamethason|brand
DDI-MedLine.d12.s6|0-6|Howeve|brand
DDI-MedLine.d12.s7|0-4|Thes|brand
DDI-MedLine.d12.s7|176-189|dose-dependen|drug_n
DDI-MedLine.d12.s7|235-237|EG|drug_n
DDI-MedLine.d24.s0|0-8|Excretio|brand
DDI-MedLine.d24.s0|13-22|thioether|group
DDI-MedLine.d24.s1|0-12|Electrophili|brand
DDI-MedLine.d24.s1|14-19|agent|group
DDI-MedLine.d24.s1|20-21|-|drug_n
DDI-MedLine.d24.s1|81-82|-|drug_n
DDI-MedLine.d24.s1|140-149|SH-bearin|brand
DDI-MedLine.d24.s3|0-3|Thi|brand
DDI-MedLine.d24.s3|136-141|agent|group
DDI-MedLine.d24.s3|152-161|precursor|group
DDI-MedLine.d24.s5|0-3|Thi|brand
DDI-MedLine.d24.s5|35-41|smoker|group
DDI-MedLine.d24.s5|58-64|worker|group
DDI-MedLine.d24.s6|0-7|Wheneve|brand
DDI-MedLine.d24.s7|0-6|Howeve|brand
DDI-MedLine.d24.s8|0-3|Mor|brand
DDI-MedLine.d65.s0|0-3|Dru|brand
DDI-MedLine.d65.s1|0-11|Interaction|brand
DDI-MedLine.d65.s1|32-37|agent|group
DDI-MedLine.d65.s1|184-199|life-endangerin|drug_n
DDI-MedLine.d65.s2|0-4|Whil|brand
DDI-MedLine.d65.s3|0-3|Thi|brand
DDI-MedLine.d65.s4|0-9|Guideline|brand
DDI-MedLine.d65.s5|0-3|Onl|brand
DDI-MedLine.d74.s0|0-8|Response|brand
DDI-MedLine.d74.s0|75-81|Chines|brand
DDI-MedLine.d74.s1|0-9|Nonketoti|brand
DDI-MedLine.d74.s1|33-38|Cines|brand
DDI-MedLine.d74.s1|40-47|hamster|group
DDI-MedLine.d74.s2|41-46|agent|group
DDI-MedLine.d74.s2|160-166|Chines|brand
DDI-MedLine.d74.s2|168-175|hamster|group
DDI-MedLine.d74.s2|275-286|theophyllin|drug
DDI-MedLine.d74.s3|0-11|Theophyllin|drug
DDI-MedLine.d74.s3|68-76|diabetic|group
DDI-MedLine.d74.s4|0-6|Glucos|brand
DDI-MedLine.d74.s4|38-49|theophyllin|drug
DDI-MedLine.d74.s4|133-142|diabectic|group
DDI-MedLine.d74.s5|0-7|Arginin|brand
DDI-MedLine.d74.s5|41-52|theophyllin|drug
DDI-MedLine.d74.s5|130-138|diabetic|group
DDI-MedLine.d74.s6|0-7|Arginin|brand
DDI-MedLine.d74.s6|39-50|theophyllin|drug
DDI-MedLine.d74.s6|94-102|diabetic|group
DDI-MedLine.d74.s6|147-155|diabetic|group
DDI-MedLine.d74.s7|0-9|Pancreati|brand
DDI-MedLine.d74.s8|0-7|Infusio|brand
DDI-MedLine.d74.s9|0-4|Thes|brand
DDI-MedLine.d74.s9|70-76|Chines|brand
DDI-MedLine.d74.s10|0-3|Thi|brand
DDI-MedLine.d74.s11|0-6|Furthe|brand
DDI-MedLine.d74.s11|49-55|Chines|brand
DDI-MedLine.d74.s11|108-119|theophyllin|drug
DDI-MedLine.d87.s0|0-2|AD|drug_n
DDI-MedLine.d87.s0|4-9|8-269|drug_n
DDI-MedLine.d87.s0|14-34|trans-3,4-dimethyl-4|drug_n
DDI-MedLine.d87.s0|36-50|3-hydroxypheny|drug_n
DDI-MedLine.d87.s0|53-62|piperidin|drug
DDI-MedLine.d87.s0|65-72|prevent|group
DDI-MedLine.d87.s1|0-9|ADL-8-269|brand
DDI-MedLine.d87.s1|93-106|opioid-induce|drug_n
DDI-MedLine.d87.s2|0-15|Gastrointestina|brand
DDI-MedLine.d87.s2|82-91|volunteer|group
DDI-MedLine.d87.s2|180-181|-|drug_n
DDI-MedLine.d87.s2|195-197|AD|drug_n
DDI-MedLine.d87.s2|199-204|8-269|drug_n
DDI-MedLine.d87.s2|252-253|-|drug_n
DDI-MedLine.d87.s2|276-285|cross-ove|drug_n
DDI-MedLine.d87.s3|0-7|Morphin|brand
DDI-MedLine.d87.s3|73-73||drug_n
DDI-MedLine.d87.s4|0-7|Morphin|brand
DDI-MedLine.d87.s4|73-73||drug_n
DDI-MedLine.d87.s4|106-108|AD|drug_n
DDI-MedLine.d87.s4|110-115|8-269|drug_n
DDI-MedLine.d87.s4|118-118||drug_n
DDI-MedLine.d87.s5|0-14|Postoperativel|brand
DDI-MedLine.d87.s5|20-27|patient|group
DDI-MedLine.d87.s5|57-68|double-blin|drug_n
DDI-MedLine.d87.s5|89-91|AD|drug_n
DDI-MedLine.d87.s5|93-98|8-269|drug_n
DDI-MedLine.d87.s6|0-8|Analgesi|brand
DDI-MedLine.d87.s7|0-7|Morphin|brand
DDI-MedLine.d87.s7|61-63|AD|drug_n
DDI-MedLine.d87.s7|65-70|8-269|drug_n
DDI-MedLine.d87.s7|99-99||drug_n
DDI-MedLine.d87.s8|17-19|AD|drug_n
DDI-MedLine.d87.s8|21-26|8-269|drug_n
DDI-MedLine.d87.s8|28-35|prevent|group
DDI-MedLine.d87.s8|37-52|morphine-induce|drug_n
DDI-MedLine.d28.s0|75-85|sensitizer|group
DDI-MedLine.d28.s1|0-3|Typ|brand
DDI-MedLine.d28.s1|62-67|Unite|brand
DDI-MedLine.d28.s1|69-74|State|brand
DDI-MedLine.d28.s2|0-4|Ther|brand
DDI-MedLine.d28.s3|0-9|Ultimatel|brand
DDI-MedLine.d28.s3|40-48|diabetic|group
DDI-MedLine.d28.s4|0-3|Thi|brand
DDI-MedLine.d28.s5|0-4|Ther|brand
DDI-MedLine.d28.s6|0-3|Thi|brand
DDI-MedLine.d28.s7|90-95|agent|group
DDI-MedLine.d28.s7|111-121|sensitizer|group
DDI-MedLine.d28.s9|0-4|Thes|brand
DDI-MedLine.d28.s9|93-104|requirement|group
DDI-MedLine.d28.s9|160-169|component|group
DDI-MedLine.d28.s10|0-8|Long-ter|brand
DDI-MedLine.d28.s10|54-72|insulin-sensitizin|drug_n
DDI-MedLine.d1.s0|1-4|Dru|brand
DDI-MedLine.d1.s0|28-36|disorder|group
DDI-MedLine.d1.s0|41-48|patient|group
DDI-MedLine.d1.s0|79-86|Erectil|brand
DDI-MedLine.d1.s0|142-149|patient|group
DDI-MedLine.d1.s1|0-4|Sinc|brand
DDI-MedLine.d1.s1|26-44|erection-supportin|drug_n
DDI-MedLine.d1.s1|58-65|patient|group
DDI-MedLine.d1.s1|163-181|erection-supportin|drug_n
DDI-MedLine.d1.s2|0-5|Sexua|brand
DDI-MedLine.d1.s2|124-133|kilometer|group
DDI-MedLine.d1.s4|76-80|user|group
DDI-MedLine.d1.s5|0-9|Sildenafi|brand
DDI-MedLine.d1.s5|33-40|patient|group
DDI-MedLine.d1.s5|48-58|long-actin|drug_n
DDI-MedLine.d1.s5|92-103|short-actin|drug_n
DDI-MedLine.d1.s6|40-52|beta-recepto|drug_n
DDI-MedLine.d1.s6|54-61|blocker|group
DDI-MedLine.d1.s6|72-82|antagonist|group
DDI-MedLine.d1.s6|103-111|diuretic|group
DDI-MedLine.d1.s6|117-119|AC|drug_n
DDI-MedLine.d1.s6|121-130|inhibitor|group
DDI-MedLine.d1.s7|0-5|Befor|brand
DDI-MedLine.d1.s7|64-71|patient|group
DDI-MedLine.d1.s8|0-8|Secondar|brand
DDI-MedLine.d1.s8|45-51|factor|group
DDI-MedLine.d1.s9|0-7|Patient|brand
DDI-MedLine.d22.s0|0-7|Spermin|brand
DDI-MedLine.d22.s1|0-7|Spermin|brand
DDI-MedLine.d22.s1|10-14|0.5-|drug_n
DDI-MedLine.d22.s1|130-138|cell-fre|drug_n
DDI-MedLine.d22.s2|13-22|spermidin|drug
DDI-MedLine.d22.s3|0-7|Spermin|brand
DDI-MedLine.d22.s3|34-43|spermidin|drug
DDI-MedLine.d22.s5|0-3|Thi|brand
DDI-MedLine.d17.s0|38-44|F2alph|brand
DDI-MedLine.d17.s1|33-39|F2alph|brand
DDI-MedLine.d17.s2|0-9|Resistanc|brand
DDI-MedLine.d17.s3|9-19|experiment|group
DDI-MedLine.d17.s3|67-75|PGF2alph|brand
DDI-MedLine.d17.s4|0-8|PGF2alph|brand
DDI-MedLine.d17.s5|9-19|experiment|group
DDI-MedLine.d17.s6|0-4|Ther|brand
DDI-MedLine.d17.s6|43-51|PGF2alph|brand
DDI-MedLine.d17.s7|70-80|experiment|group
DDI-MedLine.d17.s8|0-4|Ther|brand
DDI-MedLine.d17.s9|0-4|Ther|brand
DDI-MedLine.d17.s9|39-47|PGF2alph|brand
DDI-MedLine.d115.s0|0-10|Concomitan|brand
DDI-MedLine.d115.s0|12-27|cyclophosphamid|drug
DDI-MedLine.d115.s0|129-136|patient|group
DDI-MedLine.d115.s0|166-178|virus-relate|drug_n
DDI-MedLine.d115.s0|181-191|non-Hodgki|drug_n
DDI-MedLine.d115.s1|0-9|BACKGROUN|brand
DDI-MedLine.d115.s1|111-115|HAAR|brand
DDI-MedLine.d115.s1|138-145|patient|group
DDI-MedLine.d115.s1|182-184|HI|drug_n
DDI-MedLine.d115.s1|186-193|-relate|drug_n
DDI-MedLine.d115.s2|44-48|HAAR|brand
DDI-MedLine.d115.s2|76-83|patient|group
DDI-MedLine.d115.s2|90-100|HIV-relate|brand
DDI-MedLine.d115.s2|113-123|non-Hodgki|drug_n
DDI-MedLine.d115.s2|135-141|HIV-NH|brand
DDI-MedLine.d115.s2|149-155|author|group
DDI-MedLine.d115.s2|196-203|patient|group
DDI-MedLine.d115.s2|210-216|HIV-NH|brand
DDI-MedLine.d115.s2|244-259|cyclophosphamid|drug
DDI-MedLine.d115.s2|304-307|CHO|brand
DDI-MedLine.d115.s2|336-340|HAAR|brand
DDI-MedLine.d115.s2|361-368|patient|group
DDI-MedLine.d115.s2|392-395|CHO|brand
DDI-MedLine.d115.s2|415-423|CHOP-lik|brand
DDI-MedLine.d115.s2|440-455|cyclophosphamid|drug
DDI-MedLine.d115.s2|520-528|bleomyci|drug
DDI-MedLine.d115.s3|0-6|METHOD|brand
DDI-MedLine.d115.s3|13-20|patient|group
DDI-MedLine.d115.s3|78-83|Avian|brand
DDI-MedLine.d115.s3|85-90|Cance|brand
DDI-MedLine.d115.s3|92-97|Cente|brand
DDI-MedLine.d115.s3|100-104|Ital|brand
DDI-MedLine.d115.s3|112-116|Apri|brand
DDI-MedLine.d115.s3|126-133|Decembe|brand
DDI-MedLine.d115.s4|0-4|HAAR|brand
DDI-MedLine.d115.s4|49-55|Januar|brand
DDI-MedLine.d115.s5|0-13|Antiretrovira|brand
DDI-MedLine.d115.s5|63-72|inhibitor|group
DDI-MedLine.d115.s6|0-6|RESULT|brand
DDI-MedLine.d115.s6|75-86|demographic|group
DDI-MedLine.d115.s6|89-91|NH|drug_n
DDI-MedLine.d115.s6|93-107|characteristic|group
DDI-MedLine.d115.s6|110-112|HI|drug_n
DDI-MedLine.d115.s8|0-5|Sever|brand
DDI-MedLine.d115.s8|15-19|Grad|brand
DDI-MedLine.d115.s8|21-23|3-|drug_n
DDI-MedLine.d115.s8|42-46|Worl|brand
DDI-MedLine.d115.s8|48-53|Healt|brand
DDI-MedLine.d115.s8|55-66|Organizatio|brand
DDI-MedLine.d115.s8|111-118|patient|group
DDI-MedLine.d115.s8|133-142|CHOP-HAAR|brand
DDI-MedLine.d115.s8|162-169|patient|group
DDI-MedLine.d115.s8|184-187|CHO|brand
DDI-MedLine.d115.s8|222-222||drug_n
DDI-MedLine.d115.s9|0-9|Leukopeni|brand
DDI-MedLine.d115.s9|118-127|CHOP-HAAR|brand
DDI-MedLine.d115.s9|189-189||drug_n
DDI-MedLine.d115.s10|0-8|Seventee|brand
DDI-MedLine.d115.s10|21-30|CHOP-HAAR|brand
DDI-MedLine.d115.s10|32-39|patient|group
DDI-MedLine.d115.s10|103-106|CHO|brand
DDI-MedLine.d115.s10|108-115|patient|group
DDI-MedLine.d115.s10|142-142||drug_n
DDI-MedLine.d115.s11|18-26|follow-u|drug_n
DDI-MedLine.d115.s11|54-55|O|drug_n
DDI-MedLine.d115.s11|110-119|CHOP-HAAR|brand
DDI-MedLine.d115.s11|121-128|patient|group
DDI-MedLine.d115.s11|142-145|CHO|brand
DDI-MedLine.d115.s11|147-154|patient|group
DDI-MedLine.d115.s11|184-184||drug_n
DDI-MedLine.d115.s11|225-225||drug_n
DDI-MedLine.d115.s12|24-33|CHOP-HAAR|brand
DDI-MedLine.d115.s12|35-42|patient|group
DDI-MedLine.d115.s12|92-95|CHO|brand
DDI-MedLine.d115.s12|97-104|patient|group
DDI-MedLine.d115.s12|120-120||drug_n
DDI-MedLine.d115.s13|0-10|CONCLUSION|brand
DDI-MedLine.d115.s13|32-35|CHO|brand
DDI-MedLine.d115.s13|42-46|HAAR|brand
DDI-MedLine.d115.s13|101-107|HIV-NH|brand
DDI-MedLine.d115.s13|109-116|patient|group
DDI-MedLine.d115.s14|0-6|Howeve|brand
DDI-MedLine.d115.s15|45-49|HAAR|brand
DDI-MedLine.d71.s0|0-7|Drug-la|brand
DDI-MedLine.d71.s1|0-13|Acetylcystein|brand
DDI-MedLine.d71.s2|127-131|test|group
DDI-MedLine.d71.s3|0-10|Medication|brand
DDI-MedLine.d71.s5|0-3|Thi|brand
DDI-MedLine.d71.s5|213-217|test|group
DDI-MedLine.d140.s0|0-11|Longitudina|brand
DDI-MedLine.d140.s0|66-75|recipient|group
DDI-MedLine.d140.s0|92-106|post-transplan|drug_n
DDI-MedLine.d140.s0|114-129|pharmacokinetic|group
DDI-MedLine.d140.s0|132-148|exposure-respons|drug_n
DDI-MedLine.d140.s0|182-193|cyclosporin|drug
DDI-MedLine.d140.s1|0-8|OBJECTIV|brand
DDI-MedLine.d140.s1|49-60|steady-stat|drug_n
DDI-MedLine.d140.s1|62-77|pharmacokinetic|group
DDI-MedLine.d140.s1|97-108|cyclosporin|drug
DDI-MedLine.d140.s1|111-113|IN|drug_n
DDI-MedLine.d140.s1|177-186|recipient|group
DDI-MedLine.d140.s2|0-5|METHO|brand
DDI-MedLine.d140.s2|8-11|Thi|brand
DDI-MedLine.d140.s2|48-59|double-blin|drug_n
DDI-MedLine.d140.s2|74-81|patient|group
DDI-MedLine.d140.s2|197-208|cyclosporin|drug
DDI-MedLine.d140.s3|0-4|Bloo|brand
DDI-MedLine.d140.s3|23-38|pharmacokinetic|group
DDI-MedLine.d140.s3|58-69|cyclosporin|drug
DDI-MedLine.d140.s4|0-9|Everolimu|brand
DDI-MedLine.d140.s4|11-30|dose-proportionalit|drug_n
DDI-MedLine.d140.s4|110-114|ANOV|brand
DDI-MedLine.d140.s5|0-9|Everolimu|brand
DDI-MedLine.d140.s5|11-27|exposure-respons|drug_n
DDI-MedLine.d140.s5|72-89|concentration-tim|drug_n
DDI-MedLine.d140.s5|98-100|AU|drug_n
DDI-MedLine.d140.s5|175-187|median-effec|drug_n
DDI-MedLine.d140.s6|0-8|Potentia|brand
DDI-MedLine.d140.s6|25-36|cyclosporin|drug
DDI-MedLine.d140.s6|49-64|pharmacokinetic|group
DDI-MedLine.d140.s6|141-145|ANOV|brand
DDI-MedLine.d140.s7|0-6|RESULT|brand
DDI-MedLine.d140.s7|9-18|Everolimu|brand
DDI-MedLine.d140.s7|79-84|3-fol|drug_n
DDI-MedLine.d140.s8|0-3|Bot|brand
DDI-MedLine.d140.s8|5-16|steady-stat|drug_n
DDI-MedLine.d140.s8|44-46|AU|drug_n
DDI-MedLine.d140.s9|0-4|Ther|brand
DDI-MedLine.d140.s9|49-51|AU|drug_n
DDI-MedLine.d140.s10|52-54|AU|drug_n
DDI-MedLine.d140.s11|12-16|17-6|drug_n
DDI-MedLine.d140.s11|41-46|49-10|drug_n
DDI-MedLine.d140.s11|104-115|contributor|group
DDI-MedLine.d140.s12|0-4|Ther|brand
DDI-MedLine.d140.s12|80-81|/|drug_n
DDI-MedLine.d140.s12|111-113|AU|drug_n
DDI-MedLine.d140.s12|116-116||drug_n
DDI-MedLine.d140.s13|0-11|Cyclosporin|drug
DDI-MedLine.d140.s13|47-49|AU|drug_n
DDI-MedLine.d140.s13|136-150|co-administere|drug_n
DDI-MedLine.d140.s13|175-175||drug_n
DDI-MedLine.d140.s14|0-10|CONCLUSION|brand
DDI-MedLine.d140.s14|13-22|Everolimu|brand
DDI-MedLine.d140.s14|34-50|dose-proportiona|drug_n
DDI-MedLine.d140.s14|86-100|post-transplan|drug_n
DDI-MedLine.d140.s15|6-11|4-fol|drug_n
DDI-MedLine.d140.s15|77-88|cyclosporin|drug
DDI-MedLine.d140.s15|100-115|pharmacokinetic|group
DDI-MedLine.d62.s0|0-9|Activatio|brand
DDI-MedLine.d62.s0|26-40|immediate-earl|drug_n
DDI-MedLine.d62.s0|54-68|methamphetamin|drug
DDI-MedLine.d62.s1|3-17|immediate-earl|drug_n
DDI-MedLine.d62.s1|26-29|IEG|brand
DDI-MedLine.d62.s1|81-96|stimulus-induce|drug_n
DDI-MedLine.d62.s1|117-119|IE|drug_n
DDI-MedLine.d62.s1|141-155|methamphetamin|drug
DDI-MedLine.d62.s1|158-161|MET|brand
DDI-MedLine.d62.s1|250-261|long-lastin|drug_n
DDI-MedLine.d62.s2|0-7|Althoug|brand
DDI-MedLine.d62.s2|52-55|IEG|brand
DDI-MedLine.d62.s2|108-111|IEG|brand
DDI-MedLine.d62.s3|0-3|Her|brand
DDI-MedLine.d62.s3|31-34|MET|brand
DDI-MedLine.d62.s3|85-87|IE|drug_n
DDI-MedLine.d62.s3|94-111|activity-regulate|drug_n
DDI-MedLine.d62.s3|114-136|cytoskeleton-associate|drug_n
DDI-MedLine.d62.s4|0-4|Usin|brand
DDI-MedLine.d62.s4|46-49|MET|brand
DDI-MedLine.d62.s4|80-93|dose-dependen|drug_n
DDI-MedLine.d62.s4|202-209|dopamin|drug
DDI-MedLine.d62.s4|211-212|D|drug_n
DDI-MedLine.d62.s4|234-242|SCH-2339|brand
DDI-MedLine.d62.s5|0-3|MET|brand
DDI-MedLine.d62.s5|25-30|layer|group
DDI-MedLine.d62.s5|32-33|I|drug_n
DDI-MedLine.d62.s5|39-40|V|drug_n
DDI-MedLine.d62.s5|62-69|dopamin|drug
DDI-MedLine.d62.s6|0-4|Thes|brand
DDI-MedLine.d62.s6|27-28|D|drug_n
DDI-MedLine.d62.s6|30-38|receptor|group
DDI-MedLine.d62.s6|183-186|MET|brand
DDI-MedLine.d98.s0|0-9|Behaviora|brand
DDI-MedLine.d98.s1|0-3|Mic|brand
DDI-MedLine.d98.s1|82-102|pentobarbital-induce|drug_n
DDI-MedLine.d98.s1|120-132|long-sedatio|drug_n
DDI-MedLine.d98.s1|140-142|LS|drug_n
DDI-MedLine.d98.s1|167-169|SS|drug_n
DDI-MedLine.d98.s1|200-202|RB|drug_n
DDI-MedLine.d98.s1|225-239|cocaine-induce|drug_n
DDI-MedLine.d98.s2|0-4|Thes|brand
DDI-MedLine.d98.s3|97-102|14-da|drug_n
DDI-MedLine.d98.s3|121-123|LS|drug_n
DDI-MedLine.d98.s4|56-58|SS|drug_n
DDI-MedLine.d98.s4|102-104|RB|drug_n
DDI-MedLine.d98.s5|91-95|3-da|drug_n
DDI-MedLine.d98.s5|114-116|SS|drug_n
DDI-MedLine.d98.s5|170-172|RB|drug_n
DDI-MedLine.d98.s5|188-190|LS|drug_n
DDI-MedLine.d98.s6|86-92|factor|group
DDI-MedLine.d98.s7|0-7|Dopamin|drug
DDI-MedLine.d98.s7|10-11|D|drug_n
DDI-MedLine.d98.s7|70-72|ST|drug_n
DDI-MedLine.d98.s7|97-99|NA|drug_n
DDI-MedLine.d98.s7|110-124|cocaine-treate|drug_n
DDI-MedLine.d98.s7|157-170|saline-treate|drug_n
DDI-MedLine.d98.s8|21-22|D|drug_n
DDI-MedLine.d98.s8|31-33|NA|drug_n
DDI-MedLine.d98.s8|88-91|Bma|brand
DDI-MedLine.d98.s8|102-116|cocaine-treate|drug_n
DDI-MedLine.d98.s8|118-120|SS|drug_n
DDI-MedLine.d98.s8|126-128|RB|drug_n
DDI-MedLine.d98.s9|34-35|D|drug_n
DDI-MedLine.d98.s9|58-60|SS|drug_n
DDI-MedLine.d98.s9|70-72|RB|drug_n
DDI-MedLine.d98.s9|86-88|ST|drug_n
DDI-MedLine.d98.s9|121-135|cocaine-treate|drug_n
DDI-MedLine.d98.s10|4-6|LS|drug_n
DDI-MedLine.d98.s10|52-55|Bma|brand
DDI-MedLine.d98.s10|71-73|ST|drug_n
DDI-MedLine.d98.s10|82-84|NA|drug_n
DDI-MedLine.d98.s11|0-4|Take|brand
DDI-MedLine.d98.s11|69-70|D|drug_n
DDI-MedLine.d98.s11|79-81|NA|drug_n
DDI-MedLine.d98.s11|91-94|Bma|brand
DDI-MedLine.d98.s11|99-100|D|drug_n
DDI-MedLine.d98.s11|109-111|ST|drug_n
DDI-MedLine.d76.s0|0-8|Thiolate|brand
DDI-MedLine.d76.s1|87-91|NaCM|brand
DDI-MedLine.d76.s1|98-128|carboxymethylcellulose-cystein|drug_n
DDI-MedLine.d76.s1|131-137|CMC-Cy|brand
DDI-MedLine.d76.s1|203-207|NaFl|brand
DDI-MedLine.d76.s2|0-7|Cystein|brand
DDI-MedLine.d76.s2|57-61|NaCM|brand
DDI-MedLine.d76.s3|0-9|Iodometri|brand
DDI-MedLine.d76.s4|0-9|Permeatio|brand
DDI-MedLine.d76.s4|83-93|Ussing-typ|brand
DDI-MedLine.d76.s5|0-9|Unmodifie|brand
DDI-MedLine.d76.s5|11-15|NaCM|brand
DDI-MedLine.d76.s5|70-71|R|drug_n
DDI-MedLine.d76.s5|73-73||drug_n
DDI-MedLine.d76.s5|89-89||drug_n
DDI-MedLine.d76.s5|108-112|NaFl|brand
DDI-MedLine.d76.s5|134-138|NaCM|brand
DDI-MedLine.d76.s6|0-7|Cystein|brand
DDI-MedLine.d76.s6|60-67|R-value|brand
DDI-MedLine.d76.s7|0-9|Decreasin|brand
DDI-MedLine.d76.s7|32-38|CMC-Cy|brand
DDI-MedLine.d76.s7|88-97|CMC-Cys7.|brand
DDI-MedLine.d76.s7|142-148|R-valu|brand
DDI-MedLine.d76.s7|153-157|NaFl|brand
DDI-MedLine.d76.s8|0-4|NaCM|brand
DDI-MedLine.d76.s8|84-90|R-valu|brand
DDI-MedLine.d76.s8|95-99|NaFl|brand
DDI-MedLine.d76.s8|113-117|NaCM|brand
DDI-MedLine.d76.s9|0-10|Formulatio|brand
DDI-MedLine.d76.s9|76-80|NaCM|brand
DDI-MedLine.d76.s9|173-182|CMC-Cys7.|brand
DDI-MedLine.d76.s9|234-235|R|drug_n
DDI-MedLine.d76.s10|0-10|Conjugatio|brand
DDI-MedLine.d76.s10|15-19|NaCM|brand
DDI-MedLine.d76.s10|121-125|NaFl|brand
DDI-MedLine.d121.s0|1-11|Hippocampu|brand
DDI-MedLine.d121.s0|67-70|Mos|brand
DDI-MedLine.d121.s0|207-221|characteristic|group
DDI-MedLine.d121.s1|0-6|Animal|brand
DDI-MedLine.d121.s1|31-41|dual-memor|drug_n
DDI-MedLine.d121.s2|0-11|Specificall|brand
DDI-MedLine.d121.s3|0-6|Howeve|brand
DDI-MedLine.d121.s4|0-7|Moreove|brand
DDI-MedLine.d121.s5|0-3|Thi|brand
DDI-MedLine.d121.s5|68-76|bar-pres|drug_n
DDI-MedLine.d121.s6|0-6|Result|brand
DDI-MedLine.d121.s7|0-7|Moreove|brand
DDI-MedLine.d121.s8|0-7|Togethe|brand
DDI-MedLine.d121.s8|100-108|so-calle|drug_n
DDI-MedLine.d121.s8|111-131|hippocampal-dependen|drug_n
DDI-MedLine.d121.s9|1-23|hippocampal-independen|drug_n
DDI-MedLine.d121.s11|43-58|training-induce|drug_n
DDI-MedLine.d121.s12|0-3|Thu|brand
DDI-MedLine.d121.s12|240-247|ABSTRAC|brand
DDI-MedLine.d121.s12|249-257|TRUNCATE|brand
DDI-MedLine.d121.s12|259-260|A|drug_n
DDI-MedLine.d121.s12|266-270|WORD|brand
DDI-MedLine.d134.s0|1-9|Dose-tim|brand
DDI-MedLine.d134.s1|166-171|ClO-4|brand
DDI-MedLine.d134.s2|199-217|99m-TcO-4-injectio|drug_n
DDI-MedLine.d134.s4|43-48|offer|group
DDI-MedLine.d6.s0|0-14|Pharmacokineti|brand
DDI-MedLine.d6.s1|4-19|pharmacokinetic|group
DDI-MedLine.d6.s1|51-60|volunteer|group
DDI-MedLine.d6.s2|0-7|Etodola|brand
DDI-MedLine.d6.s2|111-116|7-hou|drug_n
DDI-MedLine.d6.s2|118-126|half-lif|drug_n
DDI-MedLine.d6.s4|0-7|Etodola|brand
DDI-MedLine.d6.s6|0-4|Sinc|brand
DDI-MedLine.d6.s6|21-32|well-define|drug_n
DDI-MedLine.d6.s6|34-64|pharmacokinetic-pharmacodynami|drug_n
DDI-MedLine.d6.s6|111-120|parameter|group
DDI-MedLine.d6.s7|0-3|Dat|brand
DDI-MedLine.d6.s7|113-125|protein-boun|drug_n
DDI-MedLine.d6.s7|172-187|pharmacokinetic|group
DDI-MedLine.d6.s8|0-8|Therefor|brand
DDI-MedLine.d6.s8|138-145|patient|group
DDI-MedLine.d6.s8|190-197|patient|group
DDI-MedLine.d111.s0|0-5|Effec|brand
DDI-MedLine.d111.s2|0-12|Acetaminophe|brand
DDI-MedLine.d111.s2|41-49|quinidin|drug
DDI-MedLine.d111.s2|52-63|theophyllin|drug
DDI-MedLine.d111.s5|0-25|acetaminophen/theophyllin|drug
DDI-MedLine.d111.s5|28-46|lidocaine/quinidin|drug
DDI-MedLine.d111.s6|0-3|Eac|brand
DDI-MedLine.d111.s7|0-8|Similarl|brand
DDI-MedLine.d111.s7|39-47|quinidin|drug
DDI-MedLine.d111.s7|54-65|theophyllin|drug
DDI-MedLine.d111.s9|0-12|Acetaminophe|brand
DDI-MedLine.d111.s9|40-51|theophyllin|drug
DDI-MedLine.d111.s9|136-138|FD|drug_n
DDI-MedLine.d111.s9|219-221|FD|drug_n
DDI-MedLine.d111.s10|0-11|Theophyllin|drug
DDI-MedLine.d111.s10|100-102|FD|drug_n
DDI-MedLine.d111.s11|73-75|FD|drug_n
DDI-MedLine.d111.s12|0-7|Valproi|brand
DDI-MedLine.d111.s12|98-100|FD|drug_n
DDI-MedLine.d111.s14|0-10|Coingestio|brand
DDI-MedLine.d111.s14|34-45|theophyllin|drug
DDI-MedLine.d2.s0|0-6|Failur|brand
DDI-MedLine.d2.s0|11-18|neomyci|drug
DDI-MedLine.d2.s0|30-33|ACT|brand
DDI-MedLine.d2.s1|0-6|Studie|brand
DDI-MedLine.d2.s1|32-39|neomyci|drug
DDI-MedLine.d2.s1|141-144|ACT|brand
DDI-MedLine.d2.s2|20-27|neomyci|drug
DDI-MedLine.d2.s2|32-35|ACT|brand
DDI-MedLine.d2.s3|0-7|Neomyci|drug
DDI-MedLine.d2.s3|71-74|ACT|brand
DDI-MedLine.d61.s0|0-14|Pharmacokineti|brand
DDI-MedLine.d61.s0|34-51|digoxin-amiodaron|drug_n
DDI-MedLine.d61.s1|0-9|Amiodaron|brand
DDI-MedLine.d61.s1|35-41|digoxi|drug
DDI-MedLine.d61.s2|0-3|Thi|brand
DDI-MedLine.d61.s3|34-40|digoxi|drug
DDI-MedLine.d61.s3|93-99|digoxi|drug
DDI-MedLine.d61.s4|0-5|Durin|brand
DDI-MedLine.d61.s4|56-62|digoxi|drug
DDI-MedLine.d61.s4|85-87|+/|drug_n
DDI-MedLine.d61.s4|105-107|+/|drug_n
DDI-MedLine.d61.s4|136-138|+/|drug_n
DDI-MedLine.d61.s5|0-3|Thi|brand
DDI-MedLine.d61.s5|61-63|+/|drug_n
DDI-MedLine.d61.s5|74-76|+/|drug_n
DDI-MedLine.d61.s5|141-143|+/|drug_n
DDI-MedLine.d61.s5|154-156|+/|drug_n
DDI-MedLine.d61.s6|0-6|Digoxi|drug
DDI-MedLine.d61.s6|8-16|half-lif|drug_n
DDI-MedLine.d61.s6|55-57|+/|drug_n
DDI-MedLine.d61.s6|68-70|+/|drug_n
DDI-MedLine.d61.s7|0-6|Digoxi|drug
DDI-MedLine.d61.s8|0-9|Amiodaron|brand
DDI-MedLine.d61.s8|20-25|three|drug_n
DDI-MedLine.d61.s8|172-178|digoxi|drug
DDI-MedLine.d61.s8|180-195|pharmacokinetic|group
DDI-MedLine.d61.s9|0-4|Thes|brand
DDI-MedLine.d61.s9|21-27|digoxi|drug
DDI-MedLine.d61.s9|29-44|pharmacokinetic|group
DDI-MedLine.d61.s9|99-105|digoxi|drug
DDI-MedLine.d91.s0|0-9|Diagnosti|brand
DDI-MedLine.d91.s2|0-6|Howeve|brand
DDI-MedLine.d91.s3|0-9|Withdrawa|brand
DDI-MedLine.d91.s4|0-4|Thes|brand
DDI-MedLine.d91.s6|0-9|Medicatio|brand
DDI-MedLine.d91.s7|0-3|Whe|brand
DDI-MedLine.d91.s7|132-138|abuser|group
DDI-MedLine.d91.s9|0-7|Recover|brand
DDI-MedLine.d91.s10|0-7|Exercis|brand
DDI-MedLine.d95.s0|17-35|resveratrol-induce|drug_n
DDI-MedLine.d95.s0|52-58|differ|group
DDI-MedLine.d95.s1|0-10|Resveratro|brand
DDI-MedLine.d95.s2|51-69|resveratrol-induce|drug_n
DDI-MedLine.d95.s2|139-153|dietary-induce|drug_n
DDI-MedLine.d95.s3|0-7|Compare|brand
DDI-MedLine.d95.s3|39-51|dietary-obes|drug_n
DDI-MedLine.d95.s3|78-78||drug_n
DDI-MedLine.d95.s3|157-177|acetylcholine-induce|drug_n
DDI-MedLine.d95.s4|0-10|Resveratro|brand
DDI-MedLine.d95.s4|13-16|5-3|drug_n
DDI-MedLine.d95.s4|38-60|concentration-dependen|drug_n
DDI-MedLine.d95.s4|184-196|dietary-obes|drug_n
DDI-MedLine.d95.s5|0-4|Ther|brand
DDI-MedLine.d95.s6|0-6|Howeve|brand
DDI-MedLine.d95.s6|9-14|L-NAM|brand
DDI-MedLine.d95.s6|100-112|dietary-obes|drug_n
DDI-MedLine.d95.s6|140-162|concentration-response|drug_n
DDI-MedLine.d95.s7|0-11|Indomethaci|brand
DDI-MedLine.d95.s7|98-110|dietary-obes|drug_n
DDI-MedLine.d95.s8|3-29|noradrenaline-precontracte|drug_n
DDI-MedLine.d95.s8|45-57|dietary-obes|drug_n
DDI-MedLine.d95.s9|0-3|Thi|brand
DDI-MedLine.d95.s9|103-115|dietary-obes|drug_n
DDI-MedLine.d95.s9|275-287|dietary-obes|drug_n
DDI-MedLine.d95.s9|312-313|N|drug_n
DDI-MedLine.d92.s0|0-7|Systemi|brand
DDI-MedLine.d92.s0|20-25|agent|group
DDI-MedLine.d92.s1|0-12|Understandin|brand
DDI-MedLine.d92.s1|52-57|agent|group
DDI-MedLine.d92.s1|119-129|side-effec|drug_n
DDI-MedLine.d92.s1|192-199|patient|group
DDI-MedLine.d21.s0|0-4|Acut|brand
DDI-MedLine.d21.s0|26-40|antidepressant|group
DDI-MedLine.d21.s0|70-81|non-diabeti|drug_n
DDI-MedLine.d21.s1|0-7|Diabeti|brand
DDI-MedLine.d21.s1|9-16|patient|group
DDI-MedLine.d21.s2|0-8|Treatmen|brand
DDI-MedLine.d21.s2|119-124|agent|group
DDI-MedLine.d21.s3|40-47|patient|group
DDI-MedLine.d21.s3|170-175|agent|group
DDI-MedLine.d21.s4|54-68|antidepressant|group
DDI-MedLine.d21.s4|112-123|non-diabeti|drug_n
DDI-MedLine.d21.s5|34-39|Wista|brand
DDI-MedLine.d21.s6|0-9|Imipramin|drug
DDI-MedLine.d21.s6|71-80|fluoxetin|drug
DDI-MedLine.d21.s7|0-4|Afte|brand
DDI-MedLine.d21.s9|0-9|Imipramin|drug
DDI-MedLine.d21.s10|0-9|Fluoxetin|drug
DDI-MedLine.d21.s11|0-9|Sertralin|brand
DDI-MedLine.d21.s12|26-37|non-diabeti|drug_n
DDI-MedLine.d21.s12|43-64|streptozotocin-induce|drug_n
DDI-MedLine.d21.s13|0-4|Agai|brand
DDI-MedLine.d21.s13|99-110|non-diabeti|drug_n
DDI-MedLine.d21.s14|0-4|Thes|brand
DDI-MedLine.d21.s15|0-9|Clonazepa|brand
DDI-MedLine.d108.s0|0-13|Administratio|brand
DDI-MedLine.d108.s0|18-24|lithiu|drug
DDI-MedLine.d108.s1|0-9|Successfu|brand
DDI-MedLine.d108.s1|26-41|manic-depressiv|drug_n
DDI-MedLine.d108.s1|91-97|lithiu|drug
DDI-MedLine.d108.s2|19-30|arrangement|group
DDI-MedLine.d108.s2|46-53|Scotlan|brand
DDI-MedLine.d108.s2|159-162|Wes|brand
DDI-MedLine.d108.s2|164-171|Midland|brand
DDI-MedLine.d55.s0|0-8|Increase|brand
DDI-MedLine.d55.s1|0-4|Sinc|brand
DDI-MedLine.d55.s1|29-43|co-administere|drug_n
DDI-MedLine.d55.s2|8-21|Sprague-Dawle|brand
DDI-MedLine.d55.s4|0-6|Carefu|brand
DDI-MedLine.d85.s0|0-11|Misonidazol|drug
DDI-MedLine.d85.s0|80-83|CCN|brand
DDI-MedLine.d85.s1|0-6|Becaus|brand
DDI-MedLine.d85.s1|24-27|CCN|brand
DDI-MedLine.d85.s1|159-174|pharmacokinetic|group
DDI-MedLine.d85.s1|184-187|CCN|brand
DDI-MedLine.d85.s1|246-257|misonidazol|drug
DDI-MedLine.d85.s2|19-21|KH|drug_n
DDI-MedLine.d85.s3|0-2|AU|drug_n
DDI-MedLine.d85.s3|38-44|1.4-1.|drug_n
DDI-MedLine.d85.s5|0-4|Thes|brand
DDI-MedLine.d85.s6|28-32|test|group
DDI-MedLine.d85.s6|51-54|CCN|brand
DDI-MedLine.d85.s6|113-125|dose-limitin|drug_n
DDI-MedLine.d85.s7|0-11|Misonidazol|drug
DDI-MedLine.d85.s7|53-56|CCN|brand
DDI-MedLine.d85.s7|76-82|factor|group
DDI-MedLine.d85.s7|85-87|DM|drug_n
DDI-MedLine.d85.s7|93-101|0.58-0.7|drug_n
DDI-MedLine.d85.s8|0-8|Similarl|brand
DDI-MedLine.d85.s8|55-57|DM|drug_n
DDI-MedLine.d85.s9|0-11|Misonidazol|drug
DDI-MedLine.d85.s9|42-45|CCN|brand
DDI-MedLine.d85.s9|47-62|pharmacokinetic|group
DDI-MedLine.d85.s11|0-11|Misonidazol|drug
DDI-MedLine.d85.s12|12-14|AU|drug_n
DDI-MedLine.d85.s12|100-102|ME|drug_n
DDI-MedLine.d85.s13|36-38|AU|drug_n
DDI-MedLine.d85.s13|55-61|factor|group
DDI-MedLine.d85.s13|83-85|ME|drug_n
DDI-MedLine.d85.s13|116-119|ml-|drug_n
DDI-MedLine.d85.s14|98-101|CCN|brand
DDI-MedLine.d85.s14|119-130|misonidazol|drug
DDI-MedLine.d85.s15|0-7|Clinica|brand
DDI-MedLine.d63.s0|0-11|Differentia|brand
DDI-MedLine.d63.s0|61-70|tail-flic|drug_n
DDI-MedLine.d63.s0|111-124|beta-endorphi|drug_n
DDI-MedLine.d63.s2|94-103|tail-flic|drug_n
DDI-MedLine.d63.s2|144-157|beta-endorphi|drug_n
DDI-MedLine.d63.s3|0-15|Intraventricula|brand
DDI-MedLine.d63.s3|30-43|beta-endorphi|drug_n
DDI-MedLine.d63.s3|88-97|tail-flic|drug_n
DDI-MedLine.d63.s4|0-10|Intratheca|brand
DDI-MedLine.d63.s4|76-87|dose-relate|drug_n
DDI-MedLine.d63.s4|123-132|tail-flic|drug_n
DDI-MedLine.d63.s4|184-197|beta-endorphi|drug_n
DDI-MedLine.d63.s4|267-276|tail-flic|drug_n
DDI-MedLine.d63.s4|317-330|beta-endorphi|drug_n
DDI-MedLine.d63.s5|41-46|12-12|drug_n
DDI-MedLine.d63.s5|95-104|tail-flic|drug_n
DDI-MedLine.d63.s6|0-15|Intraventricula|brand
DDI-MedLine.d63.s6|97-110|dose-dependen|drug_n
DDI-MedLine.d63.s6|123-132|tail-flic|drug_n
DDI-MedLine.d63.s6|173-186|beta-endorphi|drug_n
DDI-MedLine.d63.s7|35-52|naloxone-sensitiv|drug_n
DDI-MedLine.d63.s7|109-122|beta-endorphi|drug_n
DDI-MedLine.d63.s7|132-147|morphine-induce|drug_n
DDI-MedLine.d63.s7|149-158|tail-flic|drug_n
DDI-MedLine.d63.s7|206-219|beta-endorphi|drug_n
DDI-MedLine.d63.s8|38-51|beta-endorphi|drug_n
DDI-MedLine.d130.s0|0-8|High-dos|brand
DDI-MedLine.d130.s1|0-13|Nephrotoxicit|brand
DDI-MedLine.d130.s2|0-5|Sodiu|brand
DDI-MedLine.d130.s3|113-120|9.9-g/m|drug_n
DDI-MedLine.d130.s4|0-8|Cisplati|brand
DDI-MedLine.d130.s5|0-4|Usin|brand
DDI-MedLine.d130.s5|89-101|dose-limitin|drug_n
DDI-MedLine.d130.s6|0-9|Compariso|brand
DDI-MedLine.d130.s6|24-39|pharmacokinetic|group
DDI-MedLine.d130.s6|44-51|patient|group
DDI-MedLine.d130.s6|107-114|patient|group
DDI-MedLine.d130.s8|0-3|Thi|brand
DDI-MedLine.d7.s0|0-7|Enhance|brand
DDI-MedLine.d7.s0|9-20|theophyllin|drug
DDI-MedLine.d7.s0|45-53|phenytoi|drug
DDI-MedLine.d7.s1|0-3|Thi|brand
DDI-MedLine.d7.s1|41-52|theophyllin|drug
DDI-MedLine.d7.s1|102-110|phenytoi|drug
DDI-MedLine.d7.s2|0-6|Maximu|brand
DDI-MedLine.d7.s2|19-30|theophyllin|drug
DDI-MedLine.d7.s3|0-4|Onse|brand
DDI-MedLine.d7.s4|0-3|Wit|brand
DDI-MedLine.d7.s4|52-60|phenytoi|drug
DDI-MedLine.d7.s4|157-168|theophyllin|drug
DDI-MedLine.d89.s0|0-10|Therapeuti|brand
DDI-MedLine.d89.s0|71-85|99mTc-methylen|drug_n
DDI-MedLine.d89.s0|102-104|MD|drug_n
DDI-MedLine.d89.s0|106-116|-gentamici|drug_n
DDI-MedLine.d89.s1|0-9|Gentamici|brand
DDI-MedLine.d89.s1|96-108|gram-negativ|drug_n
DDI-MedLine.d89.s2|84-92|99mTc-MD|drug_n
DDI-MedLine.d89.s3|159-173|characteristic|group
DDI-MedLine.d89.s5|0-0||drug_n
DDI-MedLine.d89.s6|0-5|Seria|brand
DDI-MedLine.d89.s7|0-10|Therapeuti|brand
DDI-MedLine.d89.s7|29-31|TD|drug_n
DDI-MedLine.d89.s7|89-97|99mTc-MD|drug_n
DDI-MedLine.d89.s7|148-155|patient|group
DDI-MedLine.d26.s0|0-6|Optima|brand
DDI-MedLine.d26.s1|0-7|Interes|brand
DDI-MedLine.d26.s2|0-7|Althoug|brand
DDI-MedLine.d26.s2|99-111|dose-respons|drug_n
DDI-MedLine.d26.s2|144-149|exist|group
DDI-MedLine.d26.s2|174-184|experiment|group
DDI-MedLine.d26.s3|0-0||drug_n
DDI-MedLine.d26.s3|24-36|dose-respons|drug_n
DDI-MedLine.d26.s4|0-4|Thes|brand
DDI-MedLine.d26.s4|44-53|parameter|group
DDI-MedLine.d26.s4|158-168|experiment|group
DDI-MedLine.d26.s6|0-6|Furthe|brand
DDI-MedLine.d26.s8|0-7|Althoug|brand
DDI-MedLine.d26.s8|199-201|IJ|drug_n
DDI-MedLine.d26.s8|261-266|Barto|brand
DDI-MedLine.d26.s8|269-277|Braunber|brand
DDI-MedLine.d26.s8|284-291|Friedma|brand
DDI-MedLine.d96.s0|0-6|Jacali|brand
DDI-MedLine.d96.s0|12-22|IgA-bindin|brand
DDI-MedLine.d96.s1|37-46|Artocarpu|brand
DDI-MedLine.d96.s1|136-136||drug_n
DDI-MedLine.d96.s1|169-169||drug_n
DDI-MedLine.d96.s1|171-186|cell-independen|drug_n
DDI-MedLine.d96.s1|207-207||drug_n
DDI-MedLine.d96.s2|0-5|Durin|brand
DDI-MedLine.d96.s2|17-27|experiment|group
DDI-MedLine.d96.s4|0-3|Mor|brand
DDI-MedLine.d96.s7|0-6|Jacali|brand
DDI-MedLine.d96.s7|13-17|D-Ga|brand
DDI-MedLine.d58.s0|0-5|Effec|brand
DDI-MedLine.d58.s0|26-42|voltage-dependen|drug_n
DDI-MedLine.d58.s1|75-91|voltage-dependen|drug_n
DDI-MedLine.d58.s2|0-6|Howeve|brand
DDI-MedLine.d58.s2|44-63|ginsenosides-induce|drug_n
DDI-MedLine.d58.s2|86-93|current|group
DDI-MedLine.d58.s3|75-91|voltage-dependen|drug_n
DDI-MedLine.d58.s3|154-161|blocker|group
DDI-MedLine.d58.s3|163-172|nimodipin|drug
DDI-MedLine.d58.s3|175-180|L-typ|brand
DDI-MedLine.d58.s3|184-198|omega-conotoxi|drug_n
DDI-MedLine.d58.s3|200-203|GVI|brand
DDI-MedLine.d58.s3|206-211|N-typ|brand
DDI-MedLine.d58.s3|218-231|omega-agatoxi|drug_n
DDI-MedLine.d58.s3|233-235|IV|drug_n
DDI-MedLine.d58.s3|238-243|P-typ|brand
DDI-MedLine.d58.s4|60-76|voltage-dependen|drug_n
DDI-MedLine.d58.s4|85-92|current|group
DDI-MedLine.d58.s4|99-112|dose-dependen|drug_n
DDI-MedLine.d58.s5|4-5|I|drug_n
DDI-MedLine.d58.s6|0-9|Nimodipin|drug
DDI-MedLine.d58.s7|0-4|Thes|brand
DDI-MedLine.d58.s7|135-149|omega-conotoxi|drug_n
DDI-MedLine.d58.s7|151-164|GVIA-sensitiv|brand
DDI-MedLine.d58.s7|167-172|N-typ|brand
DDI-MedLine.d58.s7|187-200|omega-agatoxi|drug_n
DDI-MedLine.d58.s7|202-214|IVA-sensitiv|brand
DDI-MedLine.d58.s7|217-222|P-typ|brand
DDI-MedLine.d58.s7|237-262|nimodipine/omega-conotoxi|drug_n
DDI-MedLine.d58.s7|264-282|GVIA/omega-agatoxi|brand
DDI-MedLine.d58.s7|284-296|VIA-resistan|brand
DDI-MedLine.d58.s7|311-316|Q-typ|brand
DDI-MedLine.d58.s8|0-3|Thu|brand
DDI-MedLine.d58.s8|34-50|voltage-dependen|drug_n
DDI-MedLine.d82.s0|0-9|Intestina|brand
DDI-MedLine.d82.s1|41-41||drug_n
DDI-MedLine.d82.s2|97-101|80-9|drug_n
DDI-MedLine.d82.s2|126-126||drug_n
DDI-MedLine.d82.s3|0-7|Transfe|brand
DDI-MedLine.d82.s3|66-66||drug_n
DDI-MedLine.d82.s4|13-13||drug_n
DDI-MedLine.d82.s4|93-93||drug_n
DDI-MedLine.d82.s5|0-6|Howeve|brand
DDI-MedLine.d82.s5|42-42||drug_n
DDI-MedLine.d82.s5|140-140||drug_n
DDI-MedLine.d82.s6|29-29||drug_n
DDI-MedLine.d82.s7|0-10|Furthermor|brand
DDI-MedLine.d82.s8|0-6|Vitami|brand
DDI-MedLine.d82.s8|8-9|D|drug_n
DDI-MedLine.d46.s0|0-8|Influenc|brand
DDI-MedLine.d46.s0|33-42|fluoxetin|drug
DDI-MedLine.d46.s0|57-72|pharmacokinetic|group
DDI-MedLine.d46.s0|103-112|volunteer|group
DDI-MedLine.d46.s1|0-4|STUD|brand
DDI-MedLine.d46.s1|6-14|OBJECTIV|brand
DDI-MedLine.d46.s1|43-52|fluoxetin|drug
DDI-MedLine.d46.s1|61-76|pharmacokinetic|group
DDI-MedLine.d46.s2|0-5|DESIG|brand
DDI-MedLine.d46.s2|8-17|Open-labe|brand
DDI-MedLine.d46.s2|20-30|three-phas|drug_n
DDI-MedLine.d46.s3|0-6|SETTIN|brand
DDI-MedLine.d46.s3|9-16|Clinica|brand
DDI-MedLine.d46.s4|0-7|SUBJECT|brand
DDI-MedLine.d46.s4|9-14|Twelv|brand
DDI-MedLine.d46.s4|29-38|volunteer|group
DDI-MedLine.d46.s5|0-12|INTERVENTION|brand
DDI-MedLine.d46.s5|15-18|Eac|brand
DDI-MedLine.d46.s6|14-16|1-|drug_n
DDI-MedLine.d46.s7|14-17|7-1|drug_n
DDI-MedLine.d46.s8|14-18|14-4|drug_n
DDI-MedLine.d46.s8|22-31|fluoxetin|drug
DDI-MedLine.d46.s9|18-22|45-5|drug_n
DDI-MedLine.d46.s9|60-64|45-5|drug_n
DDI-MedLine.d46.s9|72-81|fluoxetin|drug
DDI-MedLine.d46.s9|99-103|45-5|drug_n
DDI-MedLine.d46.s10|0-11|MEASUREMENT|brand
DDI-MedLine.d46.s10|17-20|MAI|brand
DDI-MedLine.d46.s10|22-28|RESULT|brand
DDI-MedLine.d46.s10|31-35|Bloo|brand
DDI-MedLine.d46.s10|60-66|12-lea|drug_n
DDI-MedLine.d46.s10|115-120|point|group
DDI-MedLine.d46.s11|0-4|Bloo|brand
DDI-MedLine.d46.s12|0-17|Electrocardiogram|brand
DDI-MedLine.d46.s13|0-15|Coadministratio|brand
DDI-MedLine.d46.s13|20-29|fluoxetin|drug
DDI-MedLine.d46.s14|0-4|Ther|brand
DDI-MedLine.d46.s14|58-59|Q|drug_n
DDI-MedLine.d46.s14|120-129|fluoxetin|drug
DDI-MedLine.d46.s15|0-8|Cisaprid|brand
DDI-MedLine.d46.s15|61-70|fluoxetin|drug
DDI-MedLine.d46.s16|0-9|CONCLUSIO|brand
DDI-MedLine.d46.s16|12-20|Cisaprid|brand
DDI-MedLine.d46.s16|52-59|patient|group
DDI-MedLine.d46.s16|98-107|fluoxetin|drug
DDI-MedLine.d123.s0|0-9|Vancomyci|drug
DDI-MedLine.d123.s1|28-47|vancomycin-resistan|drug_n
DDI-MedLine.d123.s1|73-75|VR|drug_n
DDI-MedLine.d123.s2|0-3|Her|brand
DDI-MedLine.d123.s2|47-66|3,7-dihydroxyflavon|drug_n
DDI-MedLine.d123.s2|73-82|vancomyci|drug
DDI-MedLine.d123.s2|130-141|Enterococcu|brand
DDI-MedLine.d123.s2|143-150|faecali|group
DDI-MedLine.d123.s2|156-167|Enterococcu|brand
DDI-MedLine.d123.s2|193-212|vancomycin-sensitiv|drug_n
DDI-MedLine.d123.s3|0-6|Minimu|brand
DDI-MedLine.d123.s3|35-38|MIC|brand
DDI-MedLine.d123.s3|52-57|count|group
DDI-MedLine.d123.s3|78-90|Iso-sensites|brand
DDI-MedLine.d123.s4|0-3|MIC|brand
DDI-MedLine.d123.s4|8-17|vancomyci|drug
DDI-MedLine.d123.s4|129-130|-|drug_n
DDI-MedLine.d123.s5|12-13|-|drug_n
DDI-MedLine.d123.s5|60-61|-|drug_n
DDI-MedLine.d123.s5|68-87|3,7-dihydroxyflavon|drug_n
DDI-MedLine.d123.s5|105-106|-|drug_n
DDI-MedLine.d123.s6|0-5|Viabl|brand
DDI-MedLine.d123.s6|7-12|count|group
DDI-MedLine.d123.s6|31-31||drug_n
DDI-MedLine.d123.s7|0-7|faecali|group
DDI-MedLine.d123.s7|9-12|ATC|brand
DDI-MedLine.d123.s7|70-76|number|group
DDI-MedLine.d123.s7|103-106|CFU|brand
DDI-MedLine.d123.s8|0-3|CFU|brand
DDI-MedLine.d123.s8|42-44|CF|drug_n
DDI-MedLine.d123.s8|49-50|-|drug_n
DDI-MedLine.d123.s9|0-3|Thi|brand
DDI-MedLine.d123.s9|39-48|vancomyci|drug
DDI-MedLine.d125.s0|69-87|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s0|93-93||drug_n
DDI-MedLine.d125.s0|95-116|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s1|30-48|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s1|111-117|Glifto|brand
DDI-MedLine.d125.s1|120-142|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s2|50-50||drug_n
DDI-MedLine.d125.s2|53-55|AT|drug_n
DDI-MedLine.d125.s2|76-79|Mg2|brand
DDI-MedLine.d125.s2|91-109|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s2|115-115||drug_n
DDI-MedLine.d125.s2|117-138|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s3|0-13|Administratio|brand
DDI-MedLine.d125.s3|18-36|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s3|49-50|-|drug_n
DDI-MedLine.d125.s3|95-95||drug_n
DDI-MedLine.d125.s3|97-118|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s4|0-6|Animal|brand
DDI-MedLine.d125.s4|19-37|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s4|59-61|2-|drug_n
DDI-MedLine.d125.s4|89-89||drug_n
DDI-MedLine.d125.s4|91-112|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s4|201-223|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s5|38-60|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s5|65-83|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s5|91-104|NAD+-dependen|brand
DDI-MedLine.d125.s5|123-135|rate-limitin|drug_n
DDI-MedLine.d125.s5|182-182||drug_n
DDI-MedLine.d125.s5|184-205|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s5|212-234|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s6|0-4|Prio|brand
DDI-MedLine.d125.s6|24-39|4-methylpyrazol|drug
DDI-MedLine.d125.s6|51-52|-|drug_n
DDI-MedLine.d125.s6|107-129|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s6|142-143|-|drug_n
DDI-MedLine.d125.s6|163-163||drug_n
DDI-MedLine.d125.s6|165-186|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s6|257-291|1,3-difluoro-2-propanol-intoxicate|drug_n
DDI-MedLine.d125.s7|0-6|Howeve|brand
DDI-MedLine.d125.s7|27-42|4-methylpyrazol|drug
DDI-MedLine.d125.s7|54-55|-|drug_n
DDI-MedLine.d125.s7|96-114|1,3-difluoroaceton|drug_n
DDI-MedLine.d125.s7|127-128|-|drug_n
DDI-MedLine.d125.s7|175-175||drug_n
DDI-MedLine.d125.s7|177-198|-erythro-fluorocitrat|drug_n
DDI-MedLine.d125.s8|62-77|4-methylpyrazol|drug
DDI-MedLine.d125.s8|108-130|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s8|172-185|NAD+-dependen|brand
DDI-MedLine.d125.s8|224-246|1,3-difluoro-2-propano|drug_n
DDI-MedLine.d125.s8|251-269|1,3-difluoroaceton|drug_n
DDI-MedLine.d136.s0|1-8|Multipl|brand
DDI-MedLine.d136.s0|35-42|solvent|group
DDI-MedLine.d136.s0|46-49|Thi|brand
DDI-MedLine.d136.s0|66-71|paper|group
DDI-MedLine.d136.s0|143-150|solvent|group
DDI-MedLine.d136.s1|3-12|low-level|drug_n
DDI-MedLine.d136.s1|66-73|solvent|group
DDI-MedLine.d136.s1|148-153|exist|group
DDI-MedLine.d136.s2|0-9|Conversel|brand
DDI-MedLine.d136.s3|87-96|indicator|group
DDI-MedLine.d136.s3|98-104|differ|group
DDI-MedLine.d136.s4|0-12|Toxicodynami|brand
DDI-MedLine.d136.s4|35-42|solvent|group
DDI-MedLine.d136.s6|0-6|Howeve|brand
DDI-MedLine.d136.s7|14-18|list|group
DDI-MedLine.d36.s0|0-12|Carbamazepin|drug
DDI-MedLine.d36.s1|0-6|Altere|brand
DDI-MedLine.d36.s1|39-46|present|group
DDI-MedLine.d36.s2|73-85|carbamazepin|drug
DDI-MedLine.d36.s2|170-185|cross-reactivit|drug_n
DDI-MedLine.d36.s2|190-202|carbamazepin|drug
DDI-MedLine.d36.s2|243-257|antidepressant|group
DDI-MedLine.d30.s0|0-14|Stereoselectiv|brand
DDI-MedLine.d30.s0|38-57|N-allylnormetazocin|brand
DDI-MedLine.d30.s1|30-42|stereoisomer|group
DDI-MedLine.d30.s1|47-66|N-allylnormetazocin|brand
DDI-MedLine.d30.s1|69-72|NAN|brand
DDI-MedLine.d30.s1|103-115|phencyclidin|drug
DDI-MedLine.d30.s1|118-120|PC|drug_n
DDI-MedLine.d30.s1|183-196|fixed-interva|drug_n
DDI-MedLine.d30.s1|198-208|fixed-rati|drug_n
DDI-MedLine.d30.s1|211-212|F|drug_n
DDI-MedLine.d30.s1|214-215|F|drug_n
DDI-MedLine.d30.s2|0-11|Intermediat|brand
DDI-MedLine.d30.s2|25-29|-NAN|drug_n
DDI-MedLine.d30.s2|34-36|PC|drug_n
DDI-MedLine.d30.s2|70-71|F|drug_n
DDI-MedLine.d30.s2|122-123|F|drug_n
DDI-MedLine.d30.s3|23-24|F|drug_n
DDI-MedLine.d30.s3|30-31|F|drug_n
DDI-MedLine.d30.s4|32-32||drug_n
DDI-MedLine.d30.s4|34-38|-NAN|drug_n
DDI-MedLine.d30.s4|59-60|F|drug_n
DDI-MedLine.d30.s5|16-16||drug_n
DDI-MedLine.d30.s5|18-22|-NAN|drug_n
DDI-MedLine.d30.s5|34-35|F|drug_n
DDI-MedLine.d30.s5|41-42|F|drug_n
DDI-MedLine.d30.s6|13-13||drug_n
DDI-MedLine.d30.s6|15-19|-NAN|drug_n
DDI-MedLine.d30.s6|60-64|-NAN|drug_n
DDI-MedLine.d30.s6|112-112||drug_n
DDI-MedLine.d30.s6|114-118|-NAN|drug_n
DDI-MedLine.d30.s6|149-153|-NAN|drug_n
DDI-MedLine.d30.s7|18-18||drug_n
DDI-MedLine.d30.s7|20-24|-NAN|drug_n
DDI-MedLine.d30.s7|38-42|-NAN|drug_n
DDI-MedLine.d30.s7|61-75|rate-decreasin|drug_n
DDI-MedLine.d30.s7|100-101|F|drug_n
DDI-MedLine.d30.s7|107-108|F|drug_n
DDI-MedLine.d30.s8|28-28||drug_n
DDI-MedLine.d30.s8|30-34|-NAN|drug_n
DDI-MedLine.d30.s8|48-52|-NAN|drug_n
DDI-MedLine.d30.s8|57-59|PC|drug_n
DDI-MedLine.d30.s9|61-61||drug_n
DDI-MedLine.d30.s9|63-67|-NAN|drug_n
DDI-MedLine.d30.s10|66-66||drug_n
DDI-MedLine.d30.s10|68-72|-NAN|drug_n
DDI-MedLine.d30.s10|78-82|-NAN|drug_n
DDI-MedLine.d30.s10|87-89|PC|drug_n
DDI-MedLine.d30.s11|0-10|Haloperido|brand
DDI-MedLine.d30.s11|51-52|F|drug_n
DDI-MedLine.d30.s11|109-113|-NAN|drug_n
DDI-MedLine.d30.s11|118-120|PC|drug_n
DDI-MedLine.d30.s11|174-175|F|drug_n
DDI-MedLine.d30.s11|180-181|F|drug_n
DDI-MedLine.d30.s11|220-222|PC|drug_n
DDI-MedLine.d30.s11|250-253|NAN|brand
DDI-MedLine.d30.s12|88-91|NAN|brand
DDI-MedLine.d30.s13|28-44|opioid-antagonis|drug_n
DDI-MedLine.d30.s13|50-59|non-opioi|drug_n
DDI-MedLine.d30.s13|105-122|agonist-antagonis|drug_n
DDI-MedLine.d30.s14|78-80|PC|drug_n
DDI-MedLine.d29.s0|0-5|Effec|brand
DDI-MedLine.d29.s1|0-8|Accordin|brand
DDI-MedLine.d29.s1|13-19|Gibald|brand
DDI-MedLine.d29.s2|65-77|cephaloridin|drug
DDI-MedLine.d29.s3|155-162|patient|group
DDI-MedLine.d29.s4|148-153|liter|group
DDI-MedLine.d29.s5|0-3|Thu|brand
DDI-MedLine.d29.s5|24-30|Gibald|brand
DDI-MedLine.d29.s6|42-49|patient|group
DDI-MedLine.d29.s8|0-3|Thi|brand
DDI-MedLine.d49.s0|0-10|Interactio|brand
DDI-MedLine.d49.s0|15-25|clindamyci|drug
DDI-MedLine.d49.s1|41-51|clindamyci|drug
DDI-MedLine.d49.s2|18-31|Staphylococcu|brand
DDI-MedLine.d49.s2|41-51|Diplococcu|brand
DDI-MedLine.d49.s2|65-77|Streptococcu|brand
DDI-MedLine.d49.s2|141-151|Clostridiu|brand
DDI-MedLine.d49.s2|191-201|clindamyci|drug
DDI-MedLine.d49.s3|0-9|Gentamici|brand
DDI-MedLine.d49.s3|50-60|clindamyci|drug
DDI-MedLine.d49.s5|0-8|Sixty-tw|brand
DDI-MedLine.d49.s5|33-50|Enterobacteriacea|brand
DDI-MedLine.d49.s5|56-66|Pseudomona|brand
DDI-MedLine.d49.s6|0-11|Combination|brand
DDI-MedLine.d49.s6|16-26|clindamyci|drug
DDI-MedLine.d49.s7|49-59|Clostridiu|brand
DDI-MedLine.d49.s7|79-89|Escherichi|brand
DDI-MedLine.d49.s7|115-121|Proteu|brand
DDI-MedLine.d49.s7|155-165|clindamyci|drug
DDI-MedLine.d49.s8|0-11|Combination|brand
DDI-MedLine.d49.s8|16-26|clindamyci|drug
DDI-MedLine.d49.s9|0-5|Excep|brand
DDI-MedLine.d49.s9|11-31|clindamycin-sensitiv|drug_n
DDI-MedLine.d49.s10|0-9|Antagonis|brand
DDI-MedLine.d39.s0|0-5|Effec|brand
DDI-MedLine.d39.s0|23-39|endotoxin-induce|drug_n
DDI-MedLine.d39.s1|124-134|Escherichi|brand
DDI-MedLine.d39.s2|0-8|Injectio|brand
DDI-MedLine.d39.s3|49-65|endotoxin-treate|drug_n
DDI-MedLine.d39.s3|109-125|endotoxin-treate|drug_n
DDI-MedLine.d39.s3|143-144|2|drug_n
DDI-MedLine.d39.s3|149-154|5-fol|drug_n
DDI-MedLine.d39.s4|49-65|endotoxin-treate|drug_n
DDI-MedLine.d39.s4|117-133|endotoxin-treate|drug_n
DDI-MedLine.d39.s4|151-155|30-4|drug_n
DDI-MedLine.d39.s6|0-8|Exogenou|brand
DDI-MedLine.d39.s6|65-81|endotoxin-induce|drug_n
DDI-MedLine.d39.s6|95-108|dose-dependen|drug_n
DDI-MedLine.d39.s8|0-4|Thes|brand
DDI-MedLine.d40.s0|0-6|Studie|brand
DDI-MedLine.d40.s0|38-47|miconazol|drug
DDI-MedLine.d40.s0|60-69|miconazol|drug
DDI-MedLine.d40.s0|111-117|Candid|brand
DDI-MedLine.d40.s1|21-30|miconazol|drug
DDI-MedLine.d40.s1|83-89|Candid|brand
DDI-MedLine.d40.s2|0-6|Candid|brand
DDI-MedLine.d40.s3|0-9|Endogenou|brand
DDI-MedLine.d40.s4|81-86|260-n|drug_n
DDI-MedLine.d40.s5|50-55|alter|group
DDI-MedLine.d52.s0|0-10|Restoratio|brand
DDI-MedLine.d52.s0|15-24|vancomyci|drug
DDI-MedLine.d52.s0|44-55|Enterococcu|brand
DDI-MedLine.d52.s0|57-64|faecali|group
DDI-MedLine.d52.s1|52-61|vancomyci|drug
DDI-MedLine.d52.s1|83-83||drug_n
DDI-MedLine.d52.s1|86-89|Van|brand
DDI-MedLine.d52.s1|92-113|glycopeptide-resistan|drug_n
DDI-MedLine.d52.s1|115-126|Enterococcu|brand
DDI-MedLine.d52.s1|128-135|faecali|group
DDI-MedLine.d52.s2|0-10|Recombinan|brand
DDI-MedLine.d52.s2|20-26|vector|group
DDI-MedLine.d52.s2|46-58|promoter-van|drug_n
DDI-MedLine.d52.s2|99-108|vancomyci|drug
DDI-MedLine.d52.s2|220-222|RN|drug_n
DDI-MedLine.d139.s0|1-12|Quantitativ|brand
DDI-MedLine.d139.s0|50-61|neuroleptic|group
DDI-MedLine.d139.s0|159-166|patient|group
DDI-MedLine.d139.s0|173-184|neuroleptic|group
DDI-MedLine.d139.s1|0-0||drug_n
DDI-MedLine.d139.s1|11-18|patient|group
DDI-MedLine.d139.s2|48-59|neuroleptic|group
DDI-MedLine.d139.s3|0-3|Way|brand
DDI-MedLine.d139.s3|61-68|patient|group
DDI-MedLine.d139.s3|75-86|neuroleptic|group
DDI-MedLine.d88.s0|33-43|amphetamin|drug
DDI-MedLine.d88.s0|60-68|bar-pres|drug_n
DDI-MedLine.d88.s1|0-6|Studie|brand
DDI-MedLine.d88.s1|82-95|benzodiazepin|drug
DDI-MedLine.d88.s1|143-155|goal-directe|drug_n
DDI-MedLine.d88.s3|0-8|Continue|brand
DDI-MedLine.d88.s4|52-62|amphetamin|drug
DDI-MedLine.d88.s4|186-193|E-strai|brand
DDI-MedLine.d88.s4|244-251|A-strai|brand
DDI-MedLine.d88.s5|113-122|re-result|drug_n
DDI-MedLine.d88.s5|151-159|bar-pres|drug_n
DDI-MedLine.d88.s5|177-184|E-strai|brand
DDI-MedLine.d88.s5|286-293|A-strai|brand
DDI-MedLine.d122.s0|0-9|Behaviora|brand
DDI-MedLine.d122.s1|0-3|Man|brand
DDI-MedLine.d122.s1|21-27|alcoho|drug
DDI-MedLine.d122.s3|18-24|alcoho|drug
DDI-MedLine.d122.s3|85-99|characteristic|group
DDI-MedLine.d122.s4|0-7|Moreove|brand
DDI-MedLine.d122.s4|85-91|alcoho|drug
DDI-MedLine.d122.s5|0-3|Thu|brand
DDI-MedLine.d122.s5|14-20|factor|group
DDI-MedLine.d122.s6|0-4|Othe|brand
DDI-MedLine.d122.s6|6-12|factor|group
DDI-MedLine.d122.s7|0-3|Thi|brand
DDI-MedLine.d81.s0|0-10|Hypothermi|brand
DDI-MedLine.d81.s0|31-48|disulfiram-ethano|drug_n
DDI-MedLine.d81.s1|0-8|Decrease|brand
DDI-MedLine.d81.s1|88-105|disulfiram-ethano|drug_n
DDI-MedLine.d81.s1|117-119|DE|drug_n
DDI-MedLine.d81.s2|0-3|Cor|brand
DDI-MedLine.d81.s2|44-57|dose-dependen|drug_n
DDI-MedLine.d81.s6|0-6|Maxima|brand
DDI-MedLine.d81.s7|0-4|Hear|brand
DDI-MedLine.d117.s0|0-8|Increase|brand
DDI-MedLine.d117.s0|44-57|anti-apoptoti|drug_n
DDI-MedLine.d117.s2|0-16|Nucleophosmin/B2|brand
DDI-MedLine.d117.s2|21-34|serum-deprive|drug_n
DDI-MedLine.d117.s2|47-53|NIH-3T|brand
DDI-MedLine.d117.s2|100-108|half-lif|drug_n
DDI-MedLine.d117.s3|34-47|serum-deprive|drug_n
DDI-MedLine.d117.s3|49-63|ras-transforme|drug_n
DDI-MedLine.d117.s3|66-72|RAS-3T|brand
DDI-MedLine.d117.s3|106-123|serum-supplemente|drug_n
DDI-MedLine.d117.s3|125-131|NIH-3T|brand
DDI-MedLine.d117.s3|136-142|RAS-3T|brand
DDI-MedLine.d117.s4|0-8|Treatmen|brand
DDI-MedLine.d117.s4|13-19|RAS-3T|brand
DDI-MedLine.d117.s5|0-3|Muc|brand
DDI-MedLine.d117.s5|10-18|caspase-|drug_n
DDI-MedLine.d117.s5|66-79|serum-deprive|drug_n
DDI-MedLine.d117.s5|81-87|RAS-3T|brand
DDI-MedLine.d117.s5|131-144|serum-deprive|drug_n
DDI-MedLine.d117.s5|146-152|NIH-3T|brand
DDI-MedLine.d117.s6|0-3|Cel|brand
DDI-MedLine.d117.s6|15-23|caspase-|drug_n
DDI-MedLine.d117.s6|143-149|NIH-3T|brand
DDI-MedLine.d117.s7|84-90|NIH-3T|brand
DDI-MedLine.d117.s8|0-5|Unlik|brand
DDI-MedLine.d117.s8|22-36|down-regulatio|drug_n
DDI-MedLine.d117.s8|72-94|proliferation-dependen|drug_n
DDI-MedLine.d117.s8|100-109|caspase-3|drug_n
DDI-MedLine.d117.s8|115-133|apoptosis-dependen|drug_n
DDI-MedLine.d117.s9|89-97|caspase-|drug_n
DDI-MedLine.d118.s0|0-8|Sirolimu|brand
DDI-MedLine.d118.s0|31-39|rapamyci|drug
DDI-MedLine.d118.s1|0-6|Curren|brand
DDI-MedLine.d118.s2|0-8|Sirolimu|brand
DDI-MedLine.d118.s2|37-54|immunosuppressant|group
DDI-MedLine.d118.s2|231-242|cyclosporin|drug
DDI-MedLine.d118.s3|0-4|Whil|brand
DDI-MedLine.d118.s3|73-82|recipient|group
DDI-MedLine.d118.s3|128-139|cyclosporin|drug
DDI-MedLine.d118.s3|249-260|cyclosporin|drug
DDI-MedLine.d118.s3|315-319|Kell|brand
DDI-MedLine.d38.s0|0-4|Acut|brand
DDI-MedLine.d38.s0|76-88|d-amphetamin|drug
DDI-MedLine.d38.s1|0-8|RATIONAL|brand
DDI-MedLine.d38.s1|11-16|Stres|brand
DDI-MedLine.d38.s1|79-97|self-administratio|drug_n
DDI-MedLine.d38.s1|102-108|rodent|group
DDI-MedLine.d38.s2|0-6|Howeve|brand
DDI-MedLine.d38.s2|95-110|psychostimulant|group
DDI-MedLine.d38.s3|0-9|OBJECTIVE|brand
DDI-MedLine.d38.s3|15-21|examin|drug
DDI-MedLine.d38.s3|116-128|d-amphetamin|drug
DDI-MedLine.d38.s4|0-6|METHOD|brand
DDI-MedLine.d38.s4|9-22|Hydrocortison|brand
DDI-MedLine.d38.s4|37-49|d-amphetamin|drug
DDI-MedLine.d38.s4|114-123|volunteer|group
DDI-MedLine.d38.s4|130-141|four-sessio|drug_n
DDI-MedLine.d38.s4|144-161|placebo-controlle|drug_n
DDI-MedLine.d38.s4|164-177|within-subjec|drug_n
DDI-MedLine.d38.s5|49-57|rantidin|drug
DDI-MedLine.d38.s6|0-8|Dependen|brand
DDI-MedLine.d38.s6|28-40|self-reporte|drug_n
DDI-MedLine.d38.s6|71-79|Addictio|brand
DDI-MedLine.d38.s6|81-88|Researc|brand
DDI-MedLine.d38.s6|90-95|Cente|brand
DDI-MedLine.d38.s7|0-6|RESULT|brand
DDI-MedLine.d38.s7|9-22|Hydrocortison|brand
DDI-MedLine.d38.s8|0-6|Howeve|brand
DDI-MedLine.d38.s8|115-127|d-amphetamin|drug
DDI-MedLine.d38.s9|0-10|CONCLUSION|brand
DDI-MedLine.d38.s9|184-196|d-amphetamin|drug
DDI-MedLine.d18.s0|0-3|Not|brand
DDI-MedLine.d18.s0|56-63|Survant|brand
DDI-MedLine.d18.s1|63-70|Survant|brand
DDI-MedLine.d18.s2|0-6|Aeroso|brand
DDI-MedLine.d18.s2|177-187|experiment|group
DDI-MedLine.d18.s3|0-5|Powde|brand
DDI-MedLine.d18.s3|7-11|x-ra|drug_n
DDI-MedLine.d18.s6|0-7|Survant|brand
DDI-MedLine.d18.s7|0-7|Survant|brand
DDI-MedLine.d18.s8|0-7|Analysi|brand
DDI-MedLine.d18.s8|144-151|Survant|brand
DDI-MedLine.d18.s9|0-4|Thes|brand
